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ABSTRACT 
Ambergris is a large lump excreted by whales, when exposed to sunlight, air and sea water, it 
oxidatively decomposed through inorganic reactions to form different compounds including 
(-) ambrafuran. (-) Ambrafuran is a highly fragrant compound and it is considered to be a 
stronger perfume ingredient than other constituents in ambergris. It is used as a fixative agent 
to stabilize perfumes by reducing the rate of evaporation of volatile substances. A two-step 
process for production of (-) ambrafuran starting from sclareol was developed at CSIR for an 
industrial partner, Teubes cc.  The current commercial production of (-) ambrafuran entails a 
chemical process consisting of at least 8 steps and require very harsh chemicals and elevated 
temperatures. In the current study, relevant technologies for the optimization of a process for 
commercial production of (-) ambrafuran were investigated. The project objective has been to 
optimize fermentation conditions on laboratory scale for the conversion of sclareol to an 
intermediate diol using the microorganism Hyphozyma roseoniger and to subsequently test 
different zeolites for conversion of diol to (-) ambrafuran. Production of ambradiol was 
achieved in potato dextrose broth media in 13 days compared to a patented method which 
took 16 days. The method was also scaled-up in a 2 L fermentation bioreactor and the yield 
of 93% was achieved after 24 hours of reaction. Following the initial use of the zeolite 
CBV320, two new zeolites (CFG-1 and ZD0614) were identified which have the potential to 
convert ambradiol to (-) ambrafuran without undergoing an activation process. Zeolite CFG-1 
have been recognized to be highly effective for converting the intermediate ambradiol to the 
resulting (-) ambrafuran. One of the greatest outcomes of this research project is that the 
amount of zeolite required per substrate has been reduced from between 1:6 and 1:9 to 1:2. 
The substrate concentration has been increased from 5 mg/mL to 100 mg/mL which also 
resulted in the reduction of the volume of solvent required for the cyclodehydration step. The 
study allowed for scale-up and following further optimisation on larger scale should result in 
a process on commercial scale. 
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CHAPTER 1 
1. INTRODUCTION 
1.1 Ambrox 
Choudhary and Musharraf (2005) described (-) - ambrox (a trade name of Firmenich S.A) as 
a highly fragrant constituent of ambergris, which is a metabolic product of Physeter 
macrocephalus L,  commonly known as the sperm whale, digestion of squid beaks. 
Ambergris drifts in the sea for extended periods of time and during this time; it is being 
oxidatively decomposed by the action of sea water, air and sunlight, resulting into several 
inorganic reactions. The combination of these inorganic reactions result in the ambergris 
producing many odorous compounds  such as ambrinol, α-ambrinol, γ-homocyclogeranyl 
chloride, ambreine, ambrox and dihydro-γ-ionone (Tanimoto and Oritani, 1997; Barrero et 
al., 1988).  
(-) Ambrox has a strong amber-like odorous fragrance compared to its chiral compound (+) 
ambrox and has been rated as good as “Civet” and “Musk” (Martres et al., 1993). (-) Ambrox 
is also considered to be a stronger perfume ingredient/additive than (+) ambrox (Choudhary 
and Musharraf, 2005). Different techniques for (-)  ambrox and its racemate production had 
been established starting with natural occurring “sesqui or di-terpenes” compounds such as 
sclareol (Bolster et al., 2001), a compound extracted from the plant Salvia sclarea or clary 
sage as described by (Carey, 2013b).  
The reasonably high price of (-) ambrox which is estimated to be $1000 or more per kilogram 
have promoted ongoing research for new chemical synthetic routes of producing this 
compound and its derivatives.  The synthesis normally starts from low-cost natural available 
labdanes as substrates (Bolster et al., 2001). Many industries are currently using sclareol as 
the starting material for (-) ambrox production (Fráter et al., 1998), because of its 
stereochemical features that are more related to that of ambrox (Jean et al., 2001). 
1.2 Problem statement  
Consumers have developed a “chemophobia attitude” over chemical or synthetic compounds 
that are associated with food and home-care products (Krings and Berger, 1998; Vandamme, 
2003). Normally, biotechnological processes are less harmful to the environment and often 
2 
 
produce the desired enantiomeric compounds (Krings and Berger, 1998). Currently (-) 
ambrafuran, used in the fragrance industry can be obtained naturally from ambra excreted by 
whales but the whales are a threatened species, or synthetically by at least an eight step 
chemical process using harsh chemicals.  A client, Teubes cc requested the development of a 
“green process” to produce (-) ambrafuran on commercial scale so that the company can 
market the product as “natural”. 
Farbood and Willis, (1989) described the biological conversion of sclareol to ambradiol using 
the microorganism Hyphozyma roseoniger.  Steenkamp and Taka (2010) patented a method 
for the conversion of the intermediate diol to the ambrafuran (ambrox) product using zeolites. 
The drawbacks were that the zeolites have to be activated at high temperature and the high 
volume of organic solvent was not feasible on large scale and have to be optimised.  
1.3 Hypothesis  
Conditions can be optimised for the conversion of sclareol to the intermediate diol and then 
to the final (-) ambrafuran so that the process can be considered “green” and the conditions 
can be scaled up for the development of a commercial process.  The main contributors to a 
process feasible on large scale will be increasing the substrate concentration and reducing the 
volume of the organic solvent and finding the best zeolite for the process.   
1.4 OBJECTIVES OF THE STUDY 
1.4.1 Research objectives 
The overarching objective is the development of a “green” process at bench scale for the 
production of (-) ambrafuran.  The purpose of this study is to optimise the conditions for the 
process of (-) ambrafuran production starting from sclareol. The project will involve the 
optimisation of the fermentation conditions to obtain an intermediate diol from the sclareol as 
well as optimisation of conditions around the conversion of the diol to the final (-) 
ambrafuran.  This second step will involve testing different zeolites and solvents in order to 
use less solvent for the final step and to be able to scale up the complete process to bench 
scale.  The specific objectives of the research were: 
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 Development of analytical methods to separate and detect the sclareol, 
intermediate diol (ambradiol) and final product (ambrafuran) as well as 
quantification of the different compounds. 
 To obtain and test different zeolites for their ability to convert intermediate diol to 
(-) ambrafuran. 
 Test different solvents which are considered to be acceptable for use in production 
of “natural products” for optimum conversion to final product. 
 To reduce the quantity of zeolite and solvent required for conversion of the diol to 
the ambrafuran. 
 Optimise fermentation conditions at laboratory scale for convert sclareol to the 
intermediate diol using Hyphozyma roseoniger. 
 Development of a downstream process for the extraction and purification of the 
final (-) ambrafuran 
 Scale up of the complete technology to 2 L bench scale. 
. 
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CHAPTER 2 
2. LITERATURE REVIEW 
2.1 Biocatalysis 
Biocatalysis is specified as the use of enzymes and whole-cells for the conversion of 
chemical and biological materials. Both whole-cells and enzymes are widely being used as 
biocatalysts, yet whole-cell biocatalysts are considered to be advantageous over the isolated 
enzymes due to their ability to use cheap and abundant raw materials and can certainly be 
used without undergoing enzyme purification or addition of coenzymes (Goretti et al., 2013). 
Enzymes and whole-cells biocatalysts are normally suitable to produce optical pure 
stereoisomer compounds due to their complex chiral composition (Panke et al., 2004). It has 
been found that most reactions catalysed by these biological systems show great selectivity  
in terms of chemo-, regio-, and stereo-selectivity and are environmentally friendly based on 
their activity for taking place under milder conditions than chemical synthetic routes which 
uses toxic chemicals and operate under harsh conditions (Goretti et al., 2013). 
Biocatalytic methods fulfil the objectives and ethics of “green chemistry” which is becoming 
increasingly important in industrial processing (Kazlauskas and Kim, 2011). The use of 
biocatalytic methods in the production industries are highly recommended and are called 
“green processes” because they are environmentally more acceptable as they are 
sustainability, use milder conditions and due to the recyclability of the biocatalyst 
(Kazlauskas and Kim, 2011). In most cases, biocatalytic tools are considered to be 
enantioselective compared to chemical tools (Kazlauskas and Kim, 2011).   
2.2 Natural valuable fragrances  
Fragrance production started thousands years ago through extraction from natural resources 
(Serra et al., 2005). Historically, ambergris, jasmine and iris essential oil are being considered 
as the most valuable flavours and fragrance compounds (Brenna et al., 2002). These natural 
products are reported to be costly due to their low natural concentrations and considered to 
produce better results contrary to similar synthetic materials (Brenna et al., 2002). 
Biocatalytic routes for ambergris and jasmine fragrances are largely being investigated to 
completely replace or to avoid the use of chemical synthetic routes to minimise the use of 
hazardous substances (Serra et al., 2005).  
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2.3 Flavouring Compounds of Ambergris 
For many years, ambergris has been regarded as one of the most highly rated perfumery 
materials due to its extraordinary use as a fixator. The term ambergris came from the French 
“Ambre gris” which means grey amber dissociating itself from brown amber which is a 
fossilized resin. Ambergris is a substance excreted by the sperm whale (Physeter 
macrocephalus L.) as a metabolic product which possibly formed as the result of its diet or 
injuries to the gut (Ohloff, 1990). It is reported that ambergris is composed of 40-46% 
cholestanol type steroids and about 25-45% ambrein, which is a triterpene (áde Groot, 1991). 
Its possible formation remains unknown though some suggestion states that it may have been 
formed as a result of an irritation reaction occurring in the intestine of the whale (áde Groot, 
1991). When ambergris is released into the sea as a lump, is subsequently exposed to 
sunlight, air and sea water and it can be reduced into several compounds such as ambrinol, α-
ambrinol, γ-homocyclogeranyl chloride, ambreine, ambrox and dihydro-γ-ionone (Barrero et 
al., 1988). In 1954, the biggest lump of ambergris weighing around 400 kg was recovered 
from a whale killed by the Whaling Vessel Southern Harvest” and it is still regarded as the 
largest piece recovered (Bolster, 2002). 
Several chemical pathways for the degradation of ambergris have been developed in which 
some of the products are odourless while many have odours reminiscent of seaweed, wood, 
and moss with peculiar, sweetness which is a characteristic of ambergris, but with a dry 
undertone with unequalled perseverance (Hanson, 2001). One of these desired fragrances is  
(-) ambrafuran, which is considered to be the most important compound amongst the 
ambergris compounds because it possesses the animalic note characteristic of ambergris 
(Zinkel et al., 1971) 
Due to the decline in the number of whales, partly due to their hunting for the collection of 
ambergris, the hunting of the baleen whale (Physeter macrocephalus L.) is currently banned 
and alternative ways to find or produce the odorous products consisting of the ambergris 
fragrances are currently underway (Topçu et al., 1999). Currently, the ambrafuran materials 
used in perfumes are entirely from synthetic or semi-synthetic sources. Different types of 
plants such as podocarparcea (Pandanus family), Salvia sclarea (clary sage), oak moss and 
several fungi consist of compounds that can be converted to ambergris-like-odorants (Fráter, 
2000). Sclareol from clary sage is currently the most widely used starting material for 
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industrial production of ambrafuran. Several laboratory routes are presently being designed to 
produce ambrafuran and its racemate using sclareol as starting material (Bolster, 2002). 
2.4 Structural activity relationships of ambergris-odour fragrances 
It has been hypothesized that the structural elements of the labdane skeleton is highly 
associated with that of the ambergris scent, with ambrafuran being considered to be the vital 
compound amongst other ambergris odorants. The availability of a decalin skeleton with 
either one alcohol, ether or ester function and alkyl substituents at specific position is 
considered as the basic structural component of this group and all ambergris odorants contain 
these general features (Cirera, 1993). This does however not mean that compounds with 
similar features will contain amber-like-type odour and therefore configuration and 
conformational features are of great importance for odour profile and strength.  
Studies on structural activity relationships (SAR) revealed the “triaxial rule” of odor 
sensation conducted by Ohloff in 1971 as shown in the Figure 1 below (Kovatcheva et al., 
2004). Based on the outcome of the rule, it is reported that all ambergris odorants encompass 
a trans-decalin system with axial substituents in which either of these R1, R2 and R3 axial 
groups containing an oxygen atom is a geometric prerequisites for an amber-type-odour 
(Cirera, 1993).  
  
Figure 1: A diagram representing the “Triaxial rule” by Ohloff (1971) 
 
However, Vlad et al., (1983) reported that the cyclohexyltetrahydrofuran, which is an 
ambergris compound, does not contain a decalin ring system as indicated in the Figure 2 
below. 
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Figure 2: A structure of the cyclohexyltetrahydrofuran (Cheng et al., 2009) 
 
This compound led Vlad and co-workers to pursue another way of studying the ambergris 
structure odor relationship. In their findings, it is reported that all ambergris odorant 
possesses the so called “ambergris triangle” shown in Figure 3 below (Bersuker et al., 1985).
  
 
 
Figure 3: A diagram representing the “ambergris triangle” by Vlad and co-workers (Bersuker et al., 1985) 
 
It is reported that both hydrogen atoms and an oxygen atom play a critical role to the lowest 
unoccupied molecular orbitals (LUMO) of the ambergris chemicals and it is postulated that 
electron transfer occurs between the active molecules and the odorant receptor site within the 
LUMO (Bersuker et al., 1985). In 2009, a “new ambergris triangle” was reported by Cheng 
and colleagues in a follow-up studies of the ambergris structure (Cheng et al., 2009). 
 
 
 
8 
 
 
 
Figure 4: A diagram representing the “new ambergris triangle” by Cheng and colleagues (Cheng et al., 2009) 
 
The ambergris compounds such as trans- and cis-isomers of 1-[2,2,6-
trimethylcyclohexanyl]hexan-3-ol, trans- and cis-isomers of 4-isopropenyl-1,3,3,5,5-
pentamethylcyclohexanol are being used in the study that led to the formulation of the “new 
ambergris triangle” shown in Figure 4 (Cheng et al., 2009). It is  found that the  two 
hydrogen atoms and an oxygen atom were supposed to contribute to the highest occupied 
molecular orbitals (HOMO) rather than the LOMO as revealed by Vlad and co-workers 
(Cheng et al., 2009). Bersuker et al., (1985) proved that ambergris triangles determine the 
structural arrangements and the intensity of the ambergris odorants. Cheng and colleagues 
also proved that the lowest energy isomers cannot contain the strongest odor in relation to the 
other isomers (Cheng et al., 2009). 
2.4 Hyphozyma roseoniger 
It is a biocatalyst for conversion of sclareol to ambradiol. It is known as a hyphomycetes 
fungus with a yeast form  and demonstrates pink colonies when grown in yeast mold agar, 
malt extract agar, and it is light orange-pink when grown in corn meal agar (Farbood and 
Willis, 1989). It is sometimes referred to as a filamentous yeast or a yeast-like fungus (De 
Hoog and Smith, 1986). It is reported to have been extracted from soil sample found in 
central New Jersey in United States of America and the organism was characterized as 
Hyphozyma roseoniger based on its distinctive physiochemical as well as morphological 
features by Centraalbureau voor Schimmelculture and the American Type Culture Collection 
with CBS 214.83 and ATCC 20624 identities (Farbood and Willis, 1989). It forms a true 
hyphae when grown on malt extract agar, potato and rice slides after 2-3 weeks (Farbood and 
Willis, 1989) and has the ability to grow in different nutritious media (De Hoog and Smith, 
1986).  The microorganism grows from 12-30˚C (Farbood and Willis, 1989). 
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2.5 Zeolites 
Zeolites are mostly used as catalysts in cyclodehydration reactions. In 2010, Steenkamp and 
Taka reported the use of calcium type zeolite (CBV320A) for conversion of ambradiol to 
ambrafuran. They are referred to as the solid crystalline structures built with silicon, 
aluminium and oxygen that form substructures containing cavities and channels inside where 
cations, water and small molecules can be accommodated as depicted in Figure 5 (Baerlocher 
et al., 2007). They are also well known as the aluminosilicate components of microporous 
solids called molecular sieves (Wali et al., 1996). It is reported that zeolites can be naturally 
formed from volcanic rocks and ash layers reacted with alkaline ground water as compared to 
industrial zeolites which are artificially created (Rollmann et al., 2007). In this study only a 
brief general description of zeolites and their structural channelling dimensions are given. 
                   
 
Figure 5: Configuration of the zeolites with their microspore structure and dimensions 
(http://en.wikipedia.org/wiki/Zeolite accessed on 17 May 2015)   
 
Zeolites can lodge various cations including Na
+
, K
+
, Mg
2+
, Ca
2+ 
and many more in their 
microporous compartment. Their distinctive porous structure and a modifiable acidity play a 
crucial role in their efficiency  in different complex reactions (Vjunov et al., 2014). Zeolites 
acts as catalysts for various chemical reactions which take place within the internal cavities 
and it is also claimed to have dominated some processes in the field of petroleum refining as 
well as petrochemistry around early 1962 (Scherzer and Gruia, 1996). Industrial zeolites are 
usually manufactured by means of heating alumina solutions as well as silica with sodium 
hydroxide (Scherzer and Gruia, 1996). They are applicable as catalysts as well as in different 
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industries such as petrochemical, nuclear industry, biogas industry and other commercial 
industries (http://en.wikipedia.org/wiki/Zeolite accessed on 17 May 2015)   
2.6 Sclareol  
Caniard et al., (2012) described sclareol as a diterpene Natural product of high value for the 
fragrance industry. It is a commercially available labdane extracted from the flowers and 
leaves of Salvia sclarea (clary sage) which belongs to the family of Laminaceae (Schalk et 
al., 2012). Sclareol is highly rated as a potential starting material for semi-synthesis of 
various commercial compounds especially for ambrafuran production due to its labdane 
carbon skeleton and its hydroxyl group which resembles that of (-) ambrafuran (Caniard et 
al., 2012). It is primarily collected in essential oil-producing trichomes coated in flower 
calices of clary sage (Salvia sclarea), even though it has been reported that sclareol can be 
isolated from several plants such as Cistus creticus (Cistaceae), Nicotiana glutinosa 
(Solanaceae), and Cleome spinosa (Brassicaceae, but clary sage remains the most 
predominant source (Caniard et al., 2012).  
 
    
Figure 6:  A typical structure of Sclareol (Schalk, 2013) 
 
Kuźma et al., (2006) described clary sage as a biennial herb native species of Southern 
Europe, Mediterranean basin and Iran, “therefore” it is mainly cultivated for its essential oil 
in European countries like France, Hungary and Bulgaria as well as North America. 
There are two common ways of extracting sclareol from clary sage - one being where sclareol 
is extracted by means of a two-step industrial process involving hydro-distillation of the 
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aerial parts of the plant, followed by  solvent extraction of the plant material left, and the 
other technique is using  bioengineered enzyme terpene synthases “which however has been” 
reported to produce  limited product (Laville et al., 2012). Since there’s a high demand for 
sclareol for the replacement of ambergris from sperm whale for the production of 
ambrafuran, many industries are currently using apolar solvent extraction technique for 
isolation of sclareol from clary sage, as indicated in Figure 7 below (Laville et al., 2013).  
 
Apolar solvent extraction  Steam distillation  
 
 
 
 
 Apolar solvent extraction 
 
 
 
Physical purification processes 
 
 
Figure 7: An illustration of the sclareol extraction process from Clary sage (Salvia sclarea L.) (Laville et al., 2013) 
 
This illustration scheme depicts how sclareol was extracted from clary sage by apolar 
solvents on an industrial scale, generating extracts known as concretes which undergo 
physical purification processes to produce pure sclareol. Through a series of different 
mechanisms, sclareol is successfully being used as the starting material for the production of 
ambrafuran (Frija et al., 2011). 
 
Fresh clary sage 
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Essential 
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Clary sage concrete 
Distilled clary sage concrete 
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12 
 
2.7 Chemical syntheses of ambradiol (Tetranorlabdane diol) from sclareol 
Some years ago, ambradiol was reported to be produced through chemical syntheses starting 
from  sclareol in 7 steps as indicated in the diagram below (Figure 8) (Moulines et al., 2001). 
Sclareol is reported to be oxidatively degraded into sclareolide or/and ambradiol which serves 
as an important precursors for ambrafuran production. In a reaction that involved sclareol 
with 0.023 mol/mol ruthenium chloride hydrate and sodium periodate carried out in a tedious 
process (Carlsen et al., 1981), a purity of 88.5% of sclareolide with acetoxy-acid was 
produced. The main drawback in this process is the constant recovery of ruthenium salts 
(Moulines et al., 2001).  The solution for this obstacle was discovered by Moulines and co-
workers through epoxidation, Payne rearrangement and acid cyclization of sclareol to yield 
8,13-epoxylabdane-14,15-diol in solid form (Moulines et al., 2001). The 8,13-epoxylabdane-
14,15-diol was dissolved in methanol in a solution containing 53.9 mol/mol sodium periodate  
and the reaction was carried out for 16 hours at 25°C in the dark to produce 8,13-epoxy-15-
norlabdane-14-al, which underwent oxidation using Jones reagent and resulted in the 
sclareolide without traces of acetoxy-acid.  Sclareolide was then reacted with lithium 
aluminiumhydroxide (LiAlH4) for 3 hours at room temperature and reported to yield 
ambradiol.  Ambradiol is  regarded as the most suitable intermediate compound for 
ambrafuran production (Moulines et al., 2001). 
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Figure 8: Schematic representation of chemical syntheses of ambradiol from sclareol (reproduced from Steenkamp 
and Taka, 2010) 
 
 It is reported that production of ambrafuran through chemical syntheses generally results in 
racemic mixtures rather than isolated enantiomers. Therefore, alternative processes have been 
adopted where biological conversion of sclareol using microorganisms to yield either 
sclareolide or ambradiol were investigated and patented by Farbood et al., (1990). 
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2.8 Biotransformation of Sclareol to ambradiol (Tetranorlabdane diol) 
Biotransformation of terpenes is being widely considered in a number of industries, 
especially in pharmaceutical and cosmetic industries because it is reported to yield 
enantiomeric fragrance compounds under favourable conditions and such products are being 
classified as “natural”  (De Carvalho and da Fonseca, 2006).  
Biotransformation of sclareol to ambradiol using the microorganism Hyphozyma roseoniger 
with the identifications of either CBS 214.83 or ATCC 20624 was reported by Farbood and 
Willis, (1989). The organism is described to have distinct yeast and filamentous forms 
showing the same biological features and ability to perform transformations.  In 1990, 
another microorganism known as Bensingtonia ciliata (ATCC 20919) was also discovered to 
convert sclareol to ambradiol in a similar way as that of Hyphozyma roseoniger (Downey et 
al., 1990). It is reported that these microorganisms are capable of converting the sclareol to 
ambradiol under aerobic conditions between the temperature of 20-25°C in aqueous nutrient 
medium within a period of 7-15 days (Carey, 2013a). By using Bensingtonia ciliata ATCC 
20919 under aerobic conditions in aqueous nutrient medium at a temperature of 25°C, 1 g 
sclareol is reported to have resulted in 0.35 g ambradiol. Hyphozyma roseoniger CBS 214.83 
or ATCC 20624 transformed sclareol into ambradiol in aqueous nutrient medium in 10 days, 
after 3 days of cultivation at 25°C. 
Fermentation process for production of ambradiol using Hyphozyma roseoniger in an 
aqueous solution comprising nutrient media of  0.1 g NH4NO3, 0.1 g KH2PO4, 0.05 g 
MgSO4.7H2O, trace minerals, and vitamin B complex in 100 mL scale was described by 
Farbood and Willis, (1989). The microorganism was reported to have been pre-inoculated in 
the same media for 3 days and induced with 10 mg sclareol mixed with (5 mL) 50% glucose 
and (0.1 mL) Tween-80 and incubated for further 3-4 days at 25˚C on a rotatory shaker (200 
rpm). Sclareol (8 g) was dissolved in Tween-80 (8 mL) and transferred into the media for 
another 4 days to transform sclareol to ambradiol. The contents were isolated with ethyl 
acetate (200 mL) and desiccated in sodium sulphate anhydrous. A crude extract of 4 g 
ambradiol was reported to have been obtained after solvent evaporation and a purity yield of 
100% analysed by gas liquid chromatography (GLC) after recrystallization by hexane with 
chloroform, and the resulting amount of ambradiol was 2.4 g (Farbood and Willis, 1989). 
15 
 
 
Figure 9: Typical schematic representation of biological conversion of sclareol to ambradiol using microorganisms 
Hyphozyma roseoniger and Bensingtonia ciliata (Downey et al., 1990; Farbood and Willis, 1989) 
        
Conversion of sclareol to ambradiol in aqueous nutrient media consisting of 0.1 g NH4NO3, 
0.1 g KH2PO4, 0.05 g MgSO4.7H2O, with yeast extract (0.1 g) replacing trace minerals and 
vitamins from fermentation method mentioned above was also established by (Farbood and 
Willis, 1989). In this patent, sclareol was utilized at different levels (2 g, 3 g and 5 g in 100 
mL media) and reported to have been recrystallized in hexane, pulverized, sieved through 50-
mesh sieve then mixed with equivalent amount of Tween-80 before being added into the 
induction inoculum for biotransformation. The reaction was allowed to occur for a further 4 
days with the 2 g sclareol yielding 81% isolated ambradiol while 3 g and 5 g sclareol yielded 
74% and 71% isolated ambradiol respectively. In 2010, Steenkamp and Taka also reported 
the use of Hyphozyma roseoniger from ATCC to convert sclareol into ambradiol in aqueous 
medium containing yeast nitrogen base without amino acids at 20°C for 10 days as shown in 
Figure 9. It is estimated to have yielded ≥98% purity of ambradiol without any by-products 
and the structure was confirmed using LC-MS (Steenkamp and Taka, 2010).  
Farbood and Willis, (1989) further described the fermentation process for production of 
ambradiol using isolated cells (Hyphozyma roseoniger) from culture broth and washed in an 
aqueous solution of 30 µM phosphate buffer pH 7.2 after 3 days of pre-inoculum. The 
harvested and washed cells were then disseminated into the same buffer and incubated for 4 
days on a rotatory shaker (200 rpm) at 25˚C. Sclareol (0.5 g) was dissolved in Tween-80 (5 
mL) and regularly dispensed into the buffer for another 3 days to convert sclareol to 
ambradiol. Thin layer chromatography (TLC) was used to identify the progress for 
conversion of sclareol to  ambradiol and reported that 98% was attained in an isolated yield 
with a GLC purity of 99% (Farbood and Willis, 1989). 
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2.9 The syntheses of Ambrafuran 
The variety of processes for the syntheses of (-) ambrafuran is widely reported and is mainly 
divided into four major routes which are: (a) Synthesis based on the cyclization of linear or 
monocyclic precursors, (b) Synthesis starting from cyclic monoterpenoids or drimenol, (c) 
Synthesis starting from labdanes, and (d) Synthesis starting from other natural products. 
Amongst all these routes, syntheses of (-) ambrafuran from labdanes has been regarded as the 
most suitable starting material because they are easily obtained from nature (Bolster et al., 
2001). (-) Ambrafuran is being referred to as a “tetranor labdane” which is a class of 
diterpene by Bolster and co-workers, which makes it very efficient for the labdanes 
diterpenoids to be considered as the most preferred starting material for its production. In this 
study, focus will be more on syntheses of ambrox starting from labdane diterpenes, especially 
sclareol. 
2.9.1 Syntheses of ambrafuran starting from the Labdanes 
Labdanes are considered to produce massive groups of diterpenes which are often being used 
as the starting material for the production of different natural products including (-) 
ambrafuran (Swift, 2002). It has been reported that 4 carbon atoms have to be omitted from 
the labdanes through oxidative procedures, for (-) ambrafuran to be synthesized in the end 
(Bolster et al., 2001). There are many labdanes used for the production of (-) ambrafuran but 
amongst them only a few tha are reported to have been successful in the production of 
ambrafuran are selected for this discussion.  
2.9.1.1 (-) Ambrafuran production starting from labdanolic acids  
Labdanolic acid is regarded as one of the labdanes that have the possibility to act as a 
precursor in the synthesis of (-) ambrafuran and it is available in nature. It is reported to have 
been easily extracted from Cistus ladaniferus L. well known as “Rock-rose”. through steam 
distillation or by treatment of plant material with hot water (aqueous base) and soaking with 
n-Hexane, then evaporation (Bolster et al., 2001). The oxidative degradation of labdanolic 
acid is described to be very difficult due to its carboxyl group being the only functional group 
to be accessible in its side chain (Allemann and Jenny, 2001).  
Bolster and co-workers have investigated the synthesis of (-) ambrafuran from labdanolic 
acid in 7 steps as indicated in Figure 10 below. Labdanolic acid was degraded in a solution 
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containing N,N-dimethylaniline with acetyl chloride  overnight to form a pure acetate 
compound which underwent a process called iododecarboxylation which is regarded as the 
key step. The iododecarboxylation process was carried out using iodobenzenediacetate 
(IBDA) with iodine (I2) under a 100 W tungsten lamp within 45 mins to produce the iodide 
compound reported to be unstable due to contamination by iodobenzene (Bolster et al., 
2001). 
 
Figure 10: Schematic representation of synthesis of (-) ambrafuran from labdanolic acid (Allemann and Jenny, 2001) 
 
The iodide compound was treated with tert-Butoxide (tBuOK) in tertrahydrofuran (THF) at 
25°C and resulted in methyl ketone which subsequently cyclized to yield sclareol oxide.  The 
sclareol oxide was then reported to have undergone ozonolysis to remove the enol ether 
which led to the formation of an aldehyde and acetate group compound which was later 
reduced in a solution mixture of methanol and dichloromethane at -78°C to yield ambradiol 
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with 60% purity.  Ambradiol was treated with p-toluenesulfonic acid in nitromethane at room 
temperature for a period of 3 hours and resulted into 87% purity of  (-) ambrafuran (Bolster et 
al., 2001). Starting with 10 g of crude labdanolic acid, a yield of only 0.08 g (-) ambrafuran 
was achieved Bolster et al., (2001). 
2.9.1.2 Ambrafuran production starting from communic acids 
Communic acids are labdane diterpenes mostly obtained in different species of the 
Cupresaceae family (Allemann and Jenny, 2001). The trans and cis-communate are 
communic acids reported to be the most commonly used compounds for the synthesis of 
different kinds of perfumery fixatives including ambrafuran. These communic acids are 
isolated from the Juniperus sabina L of the genus Juniperus via hexane extraction and later 
crystallized for preparation of perfume fixatives (Barrero et al., 1993). As indicated in Figure 
11, communic acids contain a carboxylic group at C19, an exocyclic methylene at C8- C17 
with a dienic side chain system which is considered to be instrumental for production of 
perfume fixatives (Barrero et al., 2012). 
 
Trans and Cis-Communic acids 
Figure 11: The structure of communic acids (Barrero et al., 1993) 
    
It was reported that ambrafuran was produced in two different approaches, either from 
methyl-trans-communate and methyl-cis-communate or their mixture as shown in Figure 12 
below (Barrero et al., 1993). The first approach described the transformation of the 
communic acids (trans/cis-communate) to an aldehyde compound (compound A) in Figure 12 
by either ozonolysis at -78ºC using trioxygen (O3) in dichloromethane (CH2Cl2) or by 
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hydrogenation at 0ºC with diimide which resulted in degradation of C12-C13 by Osmium 
tetroxide (OsO4)/Sodium periodate (NaIO4) for a period of 2.5 days.  
 
Figure 12: A schematic representation for ambrafuran production from communic acids through a chemical route 
(Barrero et al., 1993) 
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The aldehyde compound was later being oxidised by acetone/Jones reagent at 0ºC and 
cyclized with p-toluenesulphonic acid (p-TsOH) in toluene by refluxing for an hour which 
resulted into the formation of γ-lactone compound (Compound B) in Figure 12.  This 
underwent a reduction by lithium aluminium hydride (LiAlH4) in tertrahydrofuran (THF) and 
proceeded for an hour at 25ºC to produce a tetrahydrofurane derivative (Compound C) in 
Figure 12. It is reported that ambrafuran was produced in 3 steps from the tetrahydrofurane 
derivative in which another aldehyde compound formed (Compound D) as shown in Figure 
12 was treated with tetrazene-water (N4H4.H2O) in potassium hydroxide (KOH) or Huang-
Minlon conditions and refluxed for an hour (Barrero et al., 1993).  
The second approach involved the direct conversion of the trans/cis-communate into a diol 
compound by ozonolysis with O3 in CH2Cl2 at -78ºC and cyclized with p-TsOH in CH3NO2 
to yield an alcohol compound which served as an intermediate of an aldehyde compound 
(Compound D) in Figure 12 (Barrero et al., 2012). It was reported that in this processes, a 
total yield of 19% ambrafuran was obtained. This process involved the use of hazardous 
chemicals and takes almost a week to reach to the final product with low yield.  
2.9.1.3 Ambrafuran production starting from sclareol 
The production of (-) ambrafuran from sclareol is highly investigated in many pharmaceutical 
industries including cosmetic industries around the world through hemisynthesis (Fráter et 
al., 1998). In most cases, sclareol is reported to have undergone three phases for ambrafuran 
production which are (a) Oxidative degradation of the side chain of sclareol, (b) The 
reduction process to yield ambradiol, and lastly (c) The cyclodehydration of ambradiol to 
form (-) ambrafuran (Allemann and Jenny, 2001). 13,14,15,16-Tetranorlabdane-diol which is  
well known as ambradiol is reported to be the easiest compound to be cyclized and an 
important intermediate for ambrafuran production in the final step (Moulines et al., 2001).  
In 1987, Decorzant and co-workers invented a two-step process for the transformation of 
sclareol to (-) ambrafuran shown in the Figure 13 below.  The side chain degradation of 
sclareol was reported to have being carried out using chromium trioxide (CrO3) that led to the 
formation of sclareolide. The two-step transformation started from the reduction of 
sclareolide by (LiAlH4) to form ambradiol which was later cyclized using β-
naphthtalenesulfonic acid and resulted into ambrafuran formation with a purity of 50% 
(Decorzant et al., 1987). 
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Figure 13: A schematic representation of ambrafuran production starting from sclareol using chemical pathways 
(Decorzant et al., 1987) 
 
Ruthenium oxide (RuO4) is reported to have substituted chromium trioxide (CrO3) in the 
degradation step of the side chain of sclareol and resulted in an increase in purity of (-) 
ambrafuran by 30% (Martres et al., 1993). Many different chemicals have been used for 
oxidation of sclareol, such as chromic acid which is reported to be problematic for use in 
industrial processes. Aluminium lithiumhydride has been proven to be unsuitable for use in 
industry because it is highly flammable (Kawanobe and Kogami, 1985). In many cases, 
chemical production of ambrafuran leads to a racemic form rather than the (-) enantiomer 
(Carey, 2013a). Therefore, the use of these hazardous chemicals in industry is not feasible 
due to lack of enantiospecificity and green processes are being proposed which are 
considered to be environmentally friendly (Steenkamp and Taka, 2010). 
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Figure 14: Shows the chemical pathway process for commercial production of ambrafuran (Steenkamp and Taka, 
2010) 
 
Eight steps are required for production of (-) ambrafuran in industry starting from sclareol as 
shown in Figure 14 above. In this process, sclareol was oxidized for 8 days via paracetic acid 
in ethyl acetate in the first step and the process is known as epoxidation. The process is 
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explained above in chemical syntheses of ambradiol section 2.7. The final step defines how 
ambradiol was converted to (-) ambrafuran. Ambradiol (10.1 g) dissolved in 100 mL dry 
tetrahydrofuran and the solution was stirred at 0˚C under nitrogen. A drop wise solution of 
1.6 M hexane n-butyllithium (26 mL) was added into a stirring solution (ambradiol & 
tetrahydrofuran) for 15 mins. Tosylchloride (7.6 g) was added and dissolved into the solution 
and cooled at 0˚C for further 15 mins. Another 1.6 M hexanic n-butyllithium (26 mL) 
solution was added in a drop wise manner while stirring for another 15 mins. A white 
precipitate was reported to have formed during the addition of 1.6 M hexanic n-butyllithium 
for the third time and the reaction was left to stir for 2 hours at room temperature. It was 
further reported that the residual material after evaporation of tetrahydrofuran was partitioned 
between 100 mL water and ethyl acetate. Brine was used to wash the ethyl acetate and dried 
on sodium sulfate anhydrous. The yield of (-) ambrafuran was reported to be 96% and 9 g 
white crystalline found after evaporation of ethyl acetate. The (-) ambrafuran elements were 
confirmed by NMR spectroscopy (Moulines et al., 2001). This commercial process takes 
long to reach to the final product and uses harsh chemicals along the way. 
The use of microorganisms such as Hyphozyma roseoniger and Bensigtonia ciliata for 
preparation of ambradiol from sclareol was reported in 1989 and it is considered to be a green 
process (Farbood and Willis, 1989) due to the use of a natural microorganism as explained in 
section 2.8.  Ambradiol is a good precursor for production of ambrafuran.  (Steenkamp and 
Taka, 2010) further invented a two-step process for producing ambrafuran starting from 
sclareol as indicated in Figure 15 below. 
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Figure 15: A schematic representation of ambrafuran production from sclareol using zeolites (Steenkamp and Taka, 
2010) 
 
The microorganism Hyphozyma roseoniger was used in the first step to transform sclareol 
into ambradiol which was later transformed to (-) ambrafuran using the zeolite CBV320 in 
hexane or toluene through a cyclization procedure as indicated in Figure 15. The zeolite 
CBV320 was heated in a conventional microwave at 500 W for activation.  The reaction was 
carried out in an orbital shaker incubator at 25˚C for 6-24 hours with a ratio of 1:6 (5 mg 
diol:30 mg zeolite CBV320) to 1:9 (5 mg diol:45 mg zeolite CBV320) ambradiol per zeolite 
in 1-20 mL of the solvent (Hexane) and the yield of 96-98% (-) ambrafuran was reported to 
have been achieved after the removal of zeolites via filtration and removing the solvent under  
reduced pressure (Steenkamp and Taka, 2010). Although it is considered as a green process, 
the problem with this method was that it involved the use of high quantities of zeolites and 
the large volume of the solvent. The activation of the zeolite which takes place in a 
conventional microwave is also a problem because at larger scale it will require a special 
microwave unit. Our study will focus on reducing the amount of zeolites by testing its 
recyclability and efficiency. Solvent reduction will also be considered. 
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CHAPTER 3 
3. MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Equipment 
Orbital shaker incubator was from New Brunswick Scientific (USA). Allegra™ X-22R 
Centrifuge with a SX4250 rotor and an AvantiTM J-25I centrifuge with a JA-14 rotor were 
from Beckman Coulter™ Inc. (California, United States), Heraeus Pico 17 Centrifuge was 
from Thermo-Scientific. DU® 800 Spectrophotometer was from Beckman Coulter™ Inc. 
Weighing balance BP 2100S from Sartorius and WAS220/X from RADWAG®. Gas 
chromatography 6890N Network system equipped with 7683B Series Injector was from 
Agilent Technologies. Gas chromatography 5890 Series II GC System was from Hewlett 
Packard HP. 2 mL Crimp Neck Vials, 32x12 mm-clear glass and Syringe Filters-Clarinert™ 
were purchased from Stargate Scientific. Restek Rtx-Sil MS W/Integra Guard 30 m x 0.25 
mm id x 0.25 µm df s/n 689000 GC column was purchased from Restek and was used for 
analysis in this study. Olympus BX40 Microscope coupled with CC12 Soft Imaging system, 
Japan. 
3.1.2 Reagents 
Hexane A.R, Heptane A.R, Ethyl Acetate A.R, and Toluene A.R were purchased from 
RADCHEM Laboratory suppliers. Diethyl Ether, Propan-2-ol HPLC, Decane, 
Dimethylsulphoxide, and Methanol were purchased from Lab Scan Analytical Science. 
Dichloromethane, Propane-1,2-diol, Chloroform, Tween 80, Ammonium nitrate, Magnesium 
Sulphate Anhydrous, Magnesium Sulphate Heptahydrate, D(+) Glucose Anhydrous, tert-
Butanol, and Yeast Extract Powder were from Merck Chemicals. 1,2-Butanediol was 
purchased from SA fine chemicals (SAFC). Tetrahydrofuran (THF) was purchased from 
Fluka Chemika. Kaiser Alumina A-2 was from Harshaw Chemie BV. Potato Dextrose Broth 
(PDB) was purchased from Scharlan Microbiology. Difco™ Yeast Nitrogen Base without 
Amino Acids was supplied by Labretoria. Sclareol (Natural) was from Ventos SA 
(ERNESTO). Hyphozyma roseoniger was purchased from CBS. Zeolites CBV320, CFG-1, 
ZD0614, CBV500-X16, CBV8062, CBV100 and Alumina were all kind gifts from Zeolyst 
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International. Water generated from a Systec VX-95 and Millipore Elix UV 5 was from 
Merk. 
3.2 Methods 
The following methods are the basis to that of the standard developed methods from CSIR 
Biosciences. The method developed at CSIR formed the basis for all the methods below.  All 
experiments were done in triplicate except where it is stated otherwise 
3.2.1 Analytical methods 
Gas chromatography-Flame Ionization Detection (FID) technique was used for analysing 
samples in the majority of this work. In this study we chose Gas Chromatography (GC) 
analysis due to its intrinsic advantages of being attractive for the characterization and 
quantitative of terpenes mixtures as investigated by (Zubyk and Conner, 1960).  
3.2.1.1 Quantitative method for analysis of sclareol, intermediate ambradiol and 
ambrafuran 
The following method is a non-chiral gas chromatography method which was used in this 
study to detect and separate sclareol, intermediate ambradiol and the final product (-) 
ambrafuran: 
Temperature gradient: 180˚C-300˚C 
Injection temperature: 270˚C 
Detection temperature (FID): 310˚C 
Rate: 15˚C/min 
Head pressure: 15 psi 
Split flow: 82.2 mL 
Septum purge: 2.63 mL/min 
Injection volume: 1 µL 
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3.2.1.2 LC-MS method used to confirm the identity of the compounds 
The following Liquid Chromatography-Mass Spectroscopy (LC-MS) method was used for 
confirmation of the characteristics of ambradiol and (-) ambrafuran in this study. A Waters 
Ultra Performance Liquid Chromatogrpahy UPLC coupled in tandem to a Waters photodiode 
array (PDA) detector and a SYNAPT G1 HDMS high definition mass spectrometer was used 
to separate the compounds and generate accurate mass data.  
Chromatographic separation of the reaction mixture was done utilising a Waters BEH C8 
column (150 mm x 2.1 mm, 1.8 µm) thermostatted at 60˚C. A binary solvent mixture was 
used consisting of water (Eluent A) containing 10 mM formic acid (natural pH of 2.3) and 
methanol (Eluent B) containing 10 mM formic acid. The initial conditions were 30% A at a 
flow rate of 0.4 mL/min for 2 mins, followed by a gradient (Curve 8) to 5% A at 6 mins. The 
conditions were kept constant for 1 min and then changed to the initial conditions. The 
runtime was 10 mins and the injection volume was 1 -3 µL depending on the concentration of 
the compounds of interest. The PDA detector was scanned between 200 nm and 500 nm (1.2 
nm resolution) and collecting 20 spectra per second. 
The SYNAPT G1 mass spectrometer was used in V-optics and operated in electrospray mode 
to detect the compounds of interest. Leucine enkephalin (50 pg/mL) was used as reference 
calibrant to obtain typical mass accuracies between 1 and 3 mDalton. The mass spectrometer 
was operated in positive ionisation mode with a capillary voltage of 3.5 kV, the sampling 
cone at 20 V and the extraction cone at 4 V. The scan time was 0.2 s covering the 100 to 800 
Dalton mass range. The source temperature was 120˚C and the desolvation temperature was 
set at 450˚C. Nitrogen gas was used as the nebulisation gas at a flow rate of 550 L/h. Mass 
accuracy was obtained using leucine encephalin as lockmass calibrant (556.2771 Da) at a 
flow rate of 0.1 mL/min to obtain a typical mass accuracy of 3 – 5 mDa. The software used to 
control the hyphenated system and do all data manipulation was MassLynx 4.1 (SCN 704).  
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3.3 Optimization processes for the production of intermediate ambradiol from sclareol 
by H. roseoniger 
3.3.1 Cell banking 
Cultivation of the biocatalytic microorganism, H. roseoniger, was conducted in 2010 at CSIR 
and the cells were placed into 2 mL cryovials as the master cell bank. The master cell banks 
were frozen at -80˚C for future use. The working cell banks were made into 1 mL cryovials 
from the master cell bank and were frozen at -80˚C. All experiments for the conversion of 
sclareol to ambradiol in this study were carried out using the working cell bank generated 
from the master cell bank as explained below. 
Potato dextrose broth (PDB) (0.53 g) was weighed into 250 mL Erlenmeyer flask and 25 mL 
dH2O was added. The media was autoclaved at 121˚C for 15 mins and cooled. H. roseoniger 
(1 mL) from a cryovial from the Master cell bank was added and placed into an orbital shaker 
incubator at 25˚C for 3 days and agitation at 180 rpm. Yeast extract (0.2 g) and 0.4 g peptone 
were weighed into 250 mL Erlenmeyer flask and 19 mL dH2O was added. The media was 
autoclaved at 121˚C for 15 mins and cooled. Glucose (1 mL) was added into the media to 
make up 20 mL. H. roseoniger (5 mL) from PDB was inoculated into the media and placed in 
an orbital shaker incubator at 25˚ for 3 days with agitation at 180 rpm. The cells were 
transferred into a sterile 50 mL Falcon tube and centrifuged at 4500 rpm for 20 mins. The 
supernatant was discarded and the cells were re-suspended in a minimal volume (20 mL) of 
100 mM potassium phosphate buffer pH 6.5. The cell suspensions were mixed with an equal 
volume (20 mL) of 50% glycerol (v/v) and 1 mL of the mixture was each transferred into the 
cryovials and placed in a freezer at -80˚C as a working cell bank.    
3.3.2 Determining the growth of H. roseoniger 
The growth of H. roseoniger was determined for 72 hours in this experiment. The pre-
inoculums were from a working cell bank 1 mL cryovial and inoculated into 100 mL PDB 
media. The experiment was conducted in triplicate as follows: 
PDB (2.65 g) was weighed into 1 L Erlenmeyer flask and 100 mL dH2O was added. The 
media was autoclaved at 121˚C for 15 mins and allowed to cool and incubated into an orbital 
shaker for 72 hours at 25°C and agitation at 180 rpm. Samples (1 mL) were collected twice a 
day into an Eppendorf tube at 0, 8, 32, 48, 56 and 72 hours. The optical density was measured 
by UV/Visible spectroscopy in 1 mL cuvettes at 600 nm.    
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3.3.3 Examination for conversion of sclareol to ambradiol using H. roseoniger in pre-
inoculums of 24, 48 and 72 hours at 25˚C 
The conversion of sclareol to ambradiol using H. roseoniger pre-inoculums of 24, 48 and 72 
hours at 25˚C was measured. The PDB media from Pronadisa was used according to the 
manufacturer’s instructions (26.5 g potato dextrose in 1 L dH2O). H. roseoniger pre-
inoculums were from 1 mL cryovials and were inoculated into 100 mL sterile (2.65 g) PDB 
media and incubated at 25˚C for 24, 48 and 72 hours respectively. The cells were induced 
with a substrate (sclareol) for 3 days in all reactions. The following method details the 
biotransformation of sclareol to ambradiol in all the pre-inoculums: 
PDB (2.65 g) was weighed into 1 L Erlenmeyer flask and 100 mL dH2O was added. The 
media was sterilized by autoclave at 121˚C for 15 mins and allowed to cool. Sclareol (20 mg) 
was added and incubated into an orbital shaker incubator at 25˚C and agitation at 180 rpm. 
Sclareol (1 g) and 1 mL Tween 80 were added into each media for 24, 48 and 72 hours 
respectively and incubated in an orbital shaker incubator at 25˚C and agitation at 180 rpm for 
7 days. Sample (1 mL) was taken into Eppendorf tubes in day 7 and mixed with 1 mL ethyl 
acetate. The mixture was centrifuged at 13000 rpm for 2 mins. The upper layers were 
collected into vials and analysed by GC. 
3.3.4 An investigation for ambradiol production using H. roseoniger from 24, 48 and 72 
hours pre-inoculums at 25˚C 
The same PDB media used in 3.3.3 was also used in this experiment. H. roseoniger from 1 
mL cryovials was pre-inoculated for 24, 48 and 72 hours in PDB media and 5 mL H. 
roseoniger from each pre-inoculum was transferred into 100 mL fresh sterile media. The cells 
were induced with a substrate (sclareol) for 3 days. The following process entails a full 
description of how this experiment was performed: 
PDB (2.65 g) was weighed into 1 L Erlenmeyer flask and 100 mL dH2O was added. The 
media was sterilized by autoclave at 121˚C for 15 mins and allowed to cool. H. roseoniger (5 
mL) from 24, 48 and 72 hours pre-inoculums was inoculated into the media. Sclareol (20 mg) 
was added and incubated in an orbital shaker incubator at 25˚C and agitation at 180 rpm for 3 
days. Sclareol (1 g) and 1 mL Tween 80 were added and incubated in an orbital shaker 
incubator at 25˚C and agitation at 180 rpm for 7 days. Sample (1 mL) was taken into 
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Eppendoff tubes in day 7 and mixed with 1 mL ethyl acetate. The mixture was centrifuged at 
13000 rpm for 2 mins. The upper layer was collected into the vial and analysed by GC.  
3.3.5 Testing different media for conversion of sclareol to ambradiol 
Different media were tested for conversion of sclareol to form intermediate ambradiol using 
H. roseoniger at 20˚C for 10 days. Experiments were done in triplicate. The H. roseoniger (1 
mL) was inoculated into 20 mL potato dextrose broth media. The cultures were grown for 3 
days at 25˚C and agitation at 180 rpm. The microorganism from this culture was then 
transferred into each media to be tested for conversion of sclareol. The following media were 
tested for production of ambradiol: (i) 0.1% NH4NO3 (w/v), 0.1% KH2PO4 (w/v), 0.05% 
MgSO4.7H2O (w/v) and Yeast extract; (ii) 0.1% NH4NO3 (w/v), 0.1% KH2PO4 (w/v), 0.05% 
MgSO4.7H2O (w/v), 0.5% (D+) Glucose (w/v) and Yeast extract; and (iii) Difco™ Yeast 
nitrogen base without amino acids with 0.1% NH4NO3 (w/v). Media were prepared as 
follows: 
 
i. Media number 1 
NH4NO3 0.1 g, 0.1 g KH2PO4, 0.05 g MgSO4.7H2O and 0.2 g Yeast extract were weighed 
into 1 L Erlenmeyer flasks and 95 mL dH2O was added into each. The media was autoclaved 
at 121˚C for 20 mins.  
ii. Media number 2 
NH4NO3 0.1 g, 0.1 g KH2PO4, 0.05 g MgSO4.7H2O, and 0.2 g Yeast extract were weighed 
into 1L Erlenmeyer flasks and 95 mL dH2O was added into each. The media was then 
autoclaved at 121˚C for 20 mins. A mass of 0.5 g dextrose in 100 mL dH2O was autoclaved 
separately and added into the media. 
iii. Media number 3 
NH4NO3 (0.1 g) was weighed into 1 L Erlenmeyer flasks and 100 mL dH2O was added to 
each. The flasks were autoclaved for 15 mins at 121˚C and allowed to cool. Difco™ Nitrogen 
base without amino acids (5 mL) was filter sterilised into each flask. 
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3.3.5.1 Procedure for sclareol conversion 
H. roseoniger (5 mL) grown as described above, was inoculated into each media in duplicate, 
1 g sclareol and 1 mL Tween 80 were added into each. The flasks were incubated for 10 days 
at 20˚C and agitation at 180 rpm. Sampling was conducted on days 1, 3, 7 and 10 by taking 
500 µL of each sample and mixing with 500 µL ethyl acetate into Eppendorf tubes. The 
mixtures were centrifuged at 13000 rpm for 2 mins and the supernatants were collected into 
vials and analysed by Gas chromatography. 
3.3.6 Recrystallization of ambradiol 
An experiment for ambradiol production was done in NH4NO3 0.1 g, 0.1 g KH2PO4, 0.05 g 
MgSO4.7H2O, 0.5 g Dextrose and 0.2 g Yeast extract (media 2) as explained in the previous 
experiment in 3.3.5. Ethyl acetate was added into the media (100 mL media per 100 mL ethyl 
acetate) and dried in MgSO4 anhydrous. The solvent was evaporated using a “rota-vapour” 
instrument and the mass of crude extracts was determined. Crude extracts (5 mg) was 
weighed into the vial and 1 mL ethyl acetate was added. The sample was analysed by GC. 
This experiment was carried out in triplicate. The crude extracts were combined and 
recrystallized as explained in the method below:  
Crude extracts (2.28 g) were dissolved in 20 mL ethyl acetate in 250 mL Erlenmeyer flask 
and boiled for 3-5 mins and allowed to warm. Hexane 500 µL was gently pipetted into the 
solution and allowed to cool at room temperature. The solution was placed in a cold room for 
overnight to allow the formation of ambradiol crystals. The solvent was decanted into another 
250 mL Erlenmeyer flask and placed in a cold room at 4˚C for further crystallization for 
overnight. The crystals was washed with 2 mL ethyl acetate and suspended into a glass plate 
and placed in a fume hood for overnight. The final amount of crystals was determined. The 
crystals (5 mg) were weighed into vial and 1 mL ethyl acetate was added. The sample was 
analysed by GC. 
3.3.7 Determining cell biomass of H. roseoniger in different media and different 
conditions for biotransformation of sclareol to ambradiol  
After testing different media for the production of ambradiol the cell biomass of the 
microorganism from different media and harvesting at various conditions were determined. 
The growth of H. roseoniger was carried out for 3 days at different temperatures using the 
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different media. In this experiment, H. roseoniger cells were harvested from the following 
media: (a) Potato dextrose broth (PDB), (b) Difco™ yeast nitrogen base without amino acids, 
(c) Difco™ yeast nitrogen base without amino acids with 1% glucose (w/v), and (d) a media 
composed of 0.2% yeast extract (w/v), 1% glucose (w/v), 0.2% NH4NO3 (w/v), 0.1% 
KH2PO4 (w/v) and 0.1% MgSO4.7H2O (w/v). 40g (D+)-Glucose was weighed into 100 mL 
Schott bottle and 80 mL dH2O was added to make up a 50% glucose (w/v) solution.  The 
glucose solution was sterilised for 20 mins at 121°C in an autoclave machine. Glucose was 
taken from the 50% glucose solution for media that required (1%) glucose and added 
aseptically. The H. roseoniger from the cryovials was initially grown in potato dextrose broth 
(PDB) for 3 days at 25˚C and agitation at 180 rpm.  Then each media (100 mL) was 
inoculated with 5 mL H. roseoniger grown in the potato dextrose broth. Substrate 20 mg 
(sclareol) was used to induce the cells before harvesting.  The original patent by Farbood and 
Willis, (1989) stated that harvested cells may be used for conversion and this was one of the 
parameters that needed to be tested. The following temperatures were used for the growth of 
H. roseoniger on each of the media above; 20˚C, 25˚C, 28˚C & 30˚C respectively. The 
conversion of sclareol to ambradiol was conducted in Difco™ yeast nitrogen base without 
amino acids or 1 mM sodium phosphate buffer pH 7.2 at 25˚C for 7 days. Both sodium 
phosphate buffer and Difco™ yeast nitrogen base were prepared as 1 L each. Difco™ yeast 
nitrogen base without amino acids was prepared according to the manufacturer’s instructions 
and entailed using 6.7 g of the Yeast nitrogen base without amino acid in 98 mL distilled 
water and 2 mL  of 50% glucose (w/v).  The glucose was sterilised separately. This 
experiment was also performed with and without cell induction. Reactions were performed in 
1 mM sodium phosphate buffer or in Difco™ yeast nitrogen base without amino acids as 
follows: 
H. roseoniger cells from the media mentioned above at different temperatures were divided 
into 2 sets of 10 mL fractions in sterile Falcon tubes. The cells were centrifuged at 4500 rpm 
for 20 min. The supernatants were discarded and the cells were re-suspended into either 50 
mL Difco™ yeast nitrogen base without amino acids or the other set in 50 mL sodium 
phosphate buffer pH 7.2. Sclareol (1 g) and 1 mL Tween 80 were added into each in a 250 
mL Erlenmeyer flask. The flasks were incubated in an orbital shaker at 25˚C and agitation at 
180 rpm for 7 days. Samples (1 mL) from each flask were taken into Eppendorf tubes on day 
1, 3, 5 and 7 respectively and mixed with 1 mL ethyl acetate. The mixtures were centrifuged 
at 13000 rpm for 2 mins. The supernatants were placed into vials and analysed by GC. 
33 
 
3.3.8 Measuring the production of ambradiol in Difco™ yeast nitrogen base without 
amino acids & potato dextrose broth at 20˚C and 25˚C using H. roseoniger  
In this experiment, induction and non-induction for conversion of sclareol to ambradiol in 
both potato dextrose broth and Difco™ yeast nitrogen base without amino acids media were 
conducted at 20˚C and 25˚C for 7-10 days. As in the previous experiments above (section 
3.3.7), microorganism (1 mL) from cryovials was inoculated into 35 mL potato dextrose 
broth (PDB). The cultures were grown for 3 days at 25°C and agitation at 180 rpm. This pre-
inoculum is used as the source of the microorganism to inoculate different media for 
determining the conversion of sclareol to the intermediate diol. The following experiments 
were conducted in duplicate following the production of the pre-inoculum:  
i. Non-induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids (YNBaa) at 20 and 25°C 
YNBaa (1.44 g) was weighed into 50 mL glass beaker and 40 mL sterile dH2O was added. 
YNBaa (5 mL) was then filter sterilized (0.45 µL filter paper) into sterilized 95 mL dH2O in 
1 L Erlenmeyer flask. H. roseoniger (5 mL) was inoculated into the flasks. Sclareol (1 g) and 
1 mL Tween 80 were added and incubated in an orbital shaker at 20˚C and agitation at 180 
rpm for 10 days. Samples (1 mL) were taken into Eppendorf tubes from day 1-10 and mixed 
with 1 mL ethyl acetate. The mixture was centrifuged at 13000 rpm for 2 mins. The upper 
layers were placed into vials and analysed by GC. 
ii. Induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids (YNBaa) at 20 and 25˚C  
YNBaa (1.44 g) was weighed into 50 mL glass beaker and 40 mL sterile dH2O was added. 
YNBaa (5 mL) was then filter sterilized (0.45 µL filter paper) into sterilized 95 mL dH2O in 
1 L Erlenmeyer flask. H. roseoniger (5 mL) was inoculated into the flasks. Sclareol (20 mg) 
was added to each flask and incubated in an orbital shaker at 20˚C and agitation at 180 rpm 
for 3 days to determine the effect of induction with a low concentration of the substrate. 
Following the initial 3 day induction, sclareol (1 g) and 1 mL Tween 80 were added and 
incubated in an orbital shaker at 20˚C and agitation at 180 rpm for 7 days. Samples (1 mL) 
were taken from day 1-7 and mixed with 1 mL ethyl acetate. The mixture was centrifuged at 
13000 rpm for 2 mins. The upper layers were collected into vials and analysed by GC.  
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iii. Non-induced reaction for ambradiol production in potato dextrose broth (PDB) 
media at 20 and 25˚C 
PDB (2.4 g) was weighed into 1L Erlenmeyer flask and 100 mL dH2O was added and 
sterilized by autoclave at 121˚C for 15 mins and allowed to cool. H. roseoniger (5 mL) was 
inoculated into the media. Sclareol (1 g) and 1 mL Tween 80 were added and incubated in an 
orbital shaker at 20˚C and agitation at 180 rpm for 10 days. Samples (1 mL) were taken from 
day 1-10 and mixed with 1 mL ethyl acetate. The mixture was centrifuged at 13000 rpm for 2 
mins. The upper layers were collected into vials and analysed by GC. 
iv. Induced reaction for ambradiol production in potato dextrose broth (PDB) 
media at 20 and 25˚C 
PDB (2.4 g) was weighed into 1 L Erlenmeyer flask and 100 mL dH2O was added and 
sterilized by autoclave at 121˚C for 15 mins and allowed to cool. H. roseoniger (5 mL) was 
inoculated into the media. Sclareol (20 mg) was added and incubated in an orbital shaker at 
20˚C and agitation at 180 rpm for 3 days. Sclareol (1 g) and 1 mL Tween 80 were added and 
incubated in an orbital shaker at 20˚C and agitation at 180 rpm for 7 days. Samples (1 mL) 
were taken into Eppendorf tubes from day 1-7 and mixed with 1 mL ethyl acetate. The 
mixture was centrifuged at 13000 rpm for 2 mins. The upper layers were collected into vials 
and analysed by GC.  
3.3.8 Testing conversion of ambradiol on a larger scale in potato dextrose broth (PDB) 
at 25˚C using H. roseoniger in an orbital shaker incubator 
In this experiment, a reaction for ambradiol production was executed in a 1 L Fernbach flask 
at a reaction scale of 700 mL. The H. roseoniger from 1 mL cryovials was inoculated into a 
35 mL sterile (16.8 g) potato dextrose broth for pre-inoculum and incubated at 25˚C for 3 
days. The cells were then induced with 140 mg sclareol for 3 days after pre-inoculum in 700 
mL potato dextrose broth. The reaction was done in triplicate as follows: 
PDB (16.8 g) was weighed into 1 L Fernbach flask and 700 mL dH2O was added. The media 
was sterilized by autoclave at 121˚C for 15 min and allowed to cool. H. roseoniger (35 mL) 
was inoculated into the media. Sclareol (140 mg) was added and incubated in an orbital 
shaker at 20˚C and agitation at 180 rpm for 3 days. Sclareol (7 g) and 7 mL Tween 80 were 
added and incubated in an orbital shaker at 25˚C and agitation at 180 rpm for 7 days. Samples 
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(1 mL) were taken into Eppendorf tubes in day 7 and mixed with 1 mL ethyl acetate. The 
mixture was centrifuged at 13000 rpm for 2 mins. The uppers layer were collected into vials 
and analysed by GC. 
3.3.10 Test for ambradiol production in 2 L fermentation bioreactor using H. roseoniger  
Conversion of sclareol to ambradiol was examined in fermentation reaction in this test in a 2 
L reaction vessel. In this trial, a reaction volume of 1.2 L was used and the H. roseoniger pre-
inoculum was prepared from 2 x 1 mL cryovials into 60 mL sterile 1.59 g PDB media and 
grown for 3 days at 25˚C.  The pre-inoculum was then transferred into the fermenter reactor 
containing sterile potato dextrose broth media 31.8 g in 1.2L dH2O and induced with 240 mg 
sclareol for 3 days.  Following induction, the sclareol was mixed with Tween 80 and 
transferred into the fermenter for biotransformation to take place. Sclareol (12 g) and 12 mL 
Tween 80 were mixed and transferred into the fermenter. The reaction took place at 25˚C, 
agitation at 300 rpm and oxygen level of 0.2% (aeration).  Sample (1 mL) was taken into 
Eppendorf tubes at 24, 31 and 48 hours and mixed with 1 mL ethyl acetate. The mixture was 
centrifuged at 13000 rpm for 2 minutes. The upper layer was collected into the vial and 
analysed by GC.  
3.4 Optimisation of processes for production of (-) Ambrafuran 
The process developed at CSIR for production of ambrafuran by zeolite CBV320 form the 
basis for the following optimized processes. The CSIR process used a ratio of 1:9 and 1:6 
(intermediate ambradiol per zeolite CBV320) as well as high volumes (5-10 mg substrate/1–
20 mL) of solvents. The zeolite has to be activated by heating in a microwave before use. In 
this study optimization of all the parameters involved in the conversion of ambradiol to (-) 
ambrafuran will be investigated.  
3.4.1 Measuring the production of (-) ambrafuran in different ratios using zeolite 
CBV320 
Zeolite CBV320 (1 g) was activated in a conventional microwave at power level of 70 W for 
3 mins. The ratios of 1:5, 1:7 and 1:9 (ambradiol per zeolite CBV320) were tested for the 
conversion of ambradiol to ambrafuran using an orbital shaker incubator at 25˚C. This 
experiment served as the basis for the upcoming series of optimised experiments. The 
reaction for each ratio was conducted in triplicate as follows: 
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Ambradiol (5 mg) and 25 mg (1:5) or 35 mg (1:7) or 45 mg (1:9) of activated zeolite 
(CBV320) were weighed into McCartney bottles. Hexane (1 mL) was added to each 
McCartney bottle and they were tightly sealed to prevent evaporation of the solvent. The 
bottles were placed into an orbital shaker incubator at 25˚C and agitation at 180 rpm for 4 
hours. At the end of the reaction, 1 mL of each sample was taken into Eppendorf tubes and 
centrifuged for 1 min at 13000 rpm. The supernatants were placed into vials and analysed by 
GC.  
3.4.2 Determining the production of (-) ambrafuran in different solvents at 1:9 ratio 
using zeolite CBV320 
In this experiment, different organic solvents were tested for the production of (-) ambrafuran 
in a ratio of 1:9 (ambradiol per zeolite). The zeolite (1g) was activated in a conventional 
microwave as previously described in 3.4.1. The purpose of this experiment was to examine 
solvents that can be used during the conversion of ambradiol to (-) ambrafuran and hexane 
was used as the reference solvent. The solvents tested included; Ethyl acetate, Hexane, 
Chloroform, Dichloromethane (DCM), 1,2-Butanediol, 1,2-Propanediol, t-Butanol, 
Isopropanol, Heptane, Toluene, Decane and Dimethylsulphoxide (DMSO). The experiment 
was conducted using all solvents mentioned above in separate reactions.  The experiment was 
conducted in duplicate for each solvent at 25˚C as follows: 
Ambradiol (5 mg) and 45 mg zeolite CBV320 were weighed into McCartney bottles; 1 mL of 
each solvent mentioned above was added. The bottles were placed into an orbital shaker 
incubator at 25˚C and agitation at 180 rpm for 4 hours. Sample (1 mL) from each reaction 
was taken into Eppendorf tubes following the 4 hour incubation reaction period and 
centrifuged for 1 min at 13000 rpm. The supernatants were collected into vials and analysed 
by GC.  
3.4.3 Different zeolites for the determination of (-) ambrafuran production 
Zeolites such as CBV500-X16, CBV8062, CBV100, CBV320 and an adsorbent, Alumina (1 
g each) were all activated at 70 W power level in a conventional microwave before use for 3 
mins. The solvent used for this set of reactions was hexane. The reactions were done in 
duplicate for each zeolite in a ratio of 1:5 at 25˚C temperature.  
37 
 
Ambradiol (20 mg) and 100 mg of each activated zeolites were weighed into McCartney 
bottles. Hexane (2 mL) was added into each bottle and tightly closed. The bottles were placed 
into an orbital shaker incubator at 25˚C and an agitation speed of 180 rpm for 6 hours. After 
the reaction, 1 mL of each sample was taken into Eppendorf tubes and centrifuged for 1 min 
at 13000 rpm. The supernatants were placed into vials and analysed using GC.  
3.4.4 Evaluation of (-) ambrafuran production in a water bath sonicator, magnetic 
stirrer plate and orbital shaker incubator 
The ratio was reduced in this experiment from 1:5, 1:7 and 1:9 to 1:3 ambradiol per zeolite. A 
water bath sonicator, magnetic stirrer plate and orbital shaker incubator instruments were 
used in this experiment for the reaction of ambradiol and zeolite CBV320 to produce 
ambrafuran. The CBV320 zeolite was initially activated in a conventional microwave at 
power level of 70 W for 3 mins. Reactions in an orbital shaker incubator and on magnetic 
stirrer plate were conducted at 25˚C. The reactions were executed in triplicate from each 
instrument mentioned above. 
Ambradiol (5 mg) and 15 mg zeolite CBV320 were weighed into McCartney bottles and 1 
mL hexane was added into each. The samples were placed either in an orbital shaker 
incubator or on a magnetic stirrer for 4 hours at 25˚C or in the sonicator water bath for 3 
hours. Samples (1 mL) from each reaction were taken into Eppendorf tubes and centrifuged 
for 1 min at 13000 rpm. The supernatants were placed into vials and analysed by GC. 
3.4.5 Measuring the production of (-) ambrafuran in a water bath sonicator using new 
zeolites 
Two new zeolites with the identity of CFG-1 and ZD0614 received as a gift from Zeolyst 
International were tested for the production of (-) ambrafuran. The experiment was carried 
out in a water bath sonicator and new zeolites used were in an activated and non-activated 
form. The zeolites were activated by heating in a conventional microwave at 70 W for 3 min. 
Ratios of 1:3 and 1:6 were used in this experiment. The experiments were performed in 
duplicate for each ratio as follows. 
Ambradiol (15 mg) and 45 mg activated zeolite CFG-1 (1:3) or 90 mg (1:6) or activated 
zeolite ZD06014 were weighed into McCartney bottles and 3 mL hexane was added into 
each. This was repeated for non-activated CFG-1 zeolite or zeolite ZD06014.  The bottles 
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were sealed and placed in a water bath sonicator for 3.5 hours. Room temperature water was 
added into the sonicator in every hour to control the temperature. After 3.5 hours, 1 mL of 
each sample was collected into Eppendorf tubes and centrifuge at 13000 rpm for 1 min. The 
supernatants were placed into vials and analysed by GC. 
3.4.6 Conversion of ambradiol to (-) ambrafuran at different temperature into an 
orbital shaker 
Different temperatures of 50, 60 and 70˚C were tested for the conversion of intermediate 
ambradiol to ambrafuran into an orbital shaker incubator. Zeolites CFG-1, ZD06014 and 
CBV320 were used in this experiment. Zeolites CFG-1 and ZD0614 were not activated 
whereas CBV320 was activated in a conventional microwave at 70 W for 3 min. The 1:3 
ratio was used and the solvent volume was reduced to 1 mL as from 3 mL used in 3.4.5. 
Reactions were conducted in triplicate for each zeolite. 
Ambradiol (5 mg) and 15 mg zeolite CFG-1, or ZD0614 or CBV320 were weighed into 
McCartney bottles and 1 mL hexane was added into each. The bottles were sealed and placed 
into an orbital shaker incubator at 50˚C for 7 hours and agitation at 180 rpm. The same 
protocol was repeated for both 60˚C and 70˚C. Sample (1 mL) was taken into Eppendorf 
tubes at the end of the reaction and centrifuged for 2 mins at 13000 rpm. The supernatants 
were placed into vials and analysed by GC.  
3.4.7 Determination of (-) ambrafuran production at low ratios using zeolites CFG-1, 
ZD0614 and CBV320 at 60˚C in orbital shaker incubator 
Ratios of 1:1 and 1:2 were determined for (-) ambrafuran production in this experiment. 
Zeolite CBV320 required activation by heating in a microwave at 70 W power level before 
use while the other two zeolites (CFG-1 and ZD0614) were used without being activated.  
Ambradiol (10 mg) and 10 mg zeolite (1:1) or 20 mg zeolite (1:2) CFG-1, ZD0614 or 
CBV320 were weighed into McCartney bottles and 1 mL hexane was added into each. The 
bottles were sealed and placed into an orbital shaker incubator at 60˚C and agitation at 180 
rpm for 6 hours. Hexane (1 mL) was added into each sample after reaction to reconstitute and 
taken into Eppendorf tubes. The samples were centrifuged for 2 mins at 13000 rpm. The 
supernatants were collected into vials and analysed by GC. 
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3.4.8 Measuring the increased concentration of ambradiol for (-) ambrafuran 
production 
Zeolite CFG-1 was used without activation as described in previous experiments. The 
experiments were conducted in triplicate for 7 hours. 
Ambradiol (100 mg) and 200 mg zeolite CFG-1 were weighed into the McCartney bottles in 
and 1 mL hexane was added into each. The bottles were sealed and placed in an orbital 
shaker incubator at 60˚C for 7 hours and agitation at 180 rpm.  Hexane (1 mL) was added 
after 7 hours reaction into each sample to reconstitute the sample and thoroughly mixed. 
Samples (1 mL) was taken into the Eppendorf tubes and centrifuged at 13000 rpm for 2 mins. 
The supernatants were taken into vials and analysed by GC. 
3.4.9 Determination of the recycled zeolite CFG-1 for production of (-) ambrafuran 
A reaction for the production of ambrafuran was done in higher concentration of ambradiol 
(100 mg) and 200 mg zeolite CFG-1 similar to the experiment above in 3.4.8. After the 
reaction, the used zeolite was washed with ethanol and incubated at 100˚C overnight. The 
zeolite (recycled) was cooled down at room temperature and used for ambrafuran production 
as explained below. The experiment was conducted in triplicate. 
Ambradiol (10 mg) and 20 mg recycled zeolite CFG-1 washed with ethanol were both 
weighed into the McCartney bottles in duplicate and 1 mL hexane was added into each. The 
bottles were sealed and placed in an orbital shaker at 60°C for 7 hours, agitation at 180 rpm.  
Hexane (1 mL) was added into each sample after 7 hours reaction and thoroughly mixed. 
Sample (1 mL) was taken into Eppendorf tubes and centrifuged at 13000 rpm for 2 mins. The 
supernatants were taken into vials and analysed by GC. 
3.4.10 Determining the production of (-) ambrafuran from impure ambradiol using 
zeolite CFG-1, CBV320 and ZD06014 
The impure ambradiol containing the two contaminating peaks was tested for ambradiol 
production with the zeolite CFG-1, CBV320 and ZD06014. The experiments were carried out 
in duplicate as explained below. 
Ambradiol (10 mg) and 20 mg zeolite CFG-1, CBV320 or ZD06014 were weighed into the 
McCartney bottles in and 1 mL hexane was added into each. The bottles were sealed and 
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placed in an orbital shaker incubator at 60˚C for 7 hours and agitation at 180 rpm.  Hexane (1 
mL) was added after 7 hours reaction into each sample to reconstitute the sample and 
thoroughly mixed. Samples (1 mL) was taken into Eppendorf tubes and centrifuged at 13000 
rpm for 2 mins. The supernatants were taken into vials and analysed by GC. 
3.4.11 Determining the effect of magnesium sulphate (MgSO4) anhydrous and 
molecular sieves for production of (-) ambrafuran at 60˚C 
This experiment involves the addition of MgSO4 anhydrous and molecular sieves in a 
reaction for (-) ambrafuran production. All the reactions were conducted at 1:2 ratio using 
zeolite CFG-1 in an orbital shaker incubator. The reactions were conducted in triplicate as 
follows. 
Ambradiol (10 mg), 20 mg zeolite CFG-1 and 3 spheres of molecular sieves or 1 micro 
spatula tip of MgSO4 anhydrous were all placed into McCartney bottles and 1 mL hexane 
was added into each.  The bottles were sealed and placed into an orbital shaker incubator at 
60˚C for 7 hours and agitation at 180 rpm.  Samples (1 mL) were each taken into Eppendorf 
tubes and centrifuged at 13000 rpm for 2 mins. The supernatants were placed into vials and 
analysed by GC. 
3.4.12 Examining (-) ambrafuran production using anhydrous activated MgSO4 & 
molecular sieves in combination with zeolite CFG-1  
MgSO4 anhydrous and molecular sieves were activated at 100˚C in an incubator for overnight 
for use in a reaction for (-) ambrafuran production. The molecular sieve spheres were crushed 
into a fine powder by pestle and mortar before activation. The reactions were performed in an 
orbital shaker incubator at 60˚C in triplicate as follows. 
Ambradiol (10 mg), 20 mg zeolite CFG-1 and 2 micro-spatulas of activated molecular sieves 
or activated MgSO4 anhydrous were all placed into McCartney bottles and 1 mL hexane was 
added into each. The bottles were sealed and placed into an orbital shaker incubator at 60˚C 
for 7 hours, agitation at 180 rpm. Hexane (1 mL) was added into each sample after reaction to 
reconstitute the reaction volume due to evaporation of the solvent and taken into Eppendorf 
tubes. The samples were centrifuged for 2 mins at 13000 rpm. The supernatants were placed 
into vials and analysed by GC. 
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3.4.13 Addition of activated MgSO4 anhydrous in a test reaction for (-) ambrafuran 
production by zeolite CFG-1 at 60˚C 
MgSO4 anhydrous was initially heated at 100˚C for 24 hours in an incubator. The amount of 
dried MgSO4 anhydrous added into the reaction was 1 g. The reaction was carried out in an 
orbital shaker incubator in triplicate at 1:2 ratios as follows.  
Ambradiol (10 mg), 20 mg zeolite CFG-1 and 0.1 g activated MgSO4 anhydrous were 
weighed into McCartney bottles and 1 mL hexane was added. The bottles were sealed and 
placed into an orbital shaker incubator at 60˚C for 7 hours and agitation at 180 rpm. Hexane 
(1 mL) was added into each sample after reaction to reconstitute and taken into Eppendorf 
tubes. The samples were centrifuged for 2 mins at 13000 rpm. The supernatants were placed 
into vials and analysed by GC. 
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CHAPTER 4 
4. RESULTS AND DISCUSSION 
4.1 Analytical  
Analyses were done using an HP Gas chromatography 5890 Series II with a Restek column. 
At a later stage of the study an Agilent Technologies GC 6890N equipped with 7683B Series 
Injector was used.  Samples were injected manually on an HP Gas chromatography 5890 
Series II, which later broke down in the middle of the project and was substituted with an 
Agilent Technologies GC 6890N equipped with 7683B Series Injector.  The different 
compounds present in the reaction mixtures as substrates or products could be separated with 
good peak resolution.  As shown in Figure 16 the (-) ambrafuran, diol and sclareol were 
separated and eluted at 3.040, 4.457 and 5.209 mins retention times “respectively”. The 
results are presented as area percentage of each compound as the triplicates showed good 
reproducibility (less than 2% difference) using these parameters.  
 
 
 
Figure 16: Illustrates the chromatogram for (-) ambrafuran, ambradiol and sclareol with their retention times 
separated by GC 
 
The use of area percentage in GC analysis is well known and is defined as the area under a 
gas-chromatograph peak which is proportional to the amount (moles) of compound eluted. 
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Hence, the molar percentage composition of a mixture can be approximated by comparing 
relative peak areas.  The calculation is done as illustrated in Figure 17 below. 
 
 
Figure 17: Calculation of the area percentage (http://quiz2.chem.arizona.edu/vip/chromatography/GC/analysis.htm 
accessed on 10/06/2015) 
h - The height of the peak above the baseline and w1/2- the width of the peak at half of it height 
 
It was difficult to obtain accurate amounts of product produced from the GC results as the 
injections were done manually and 1 µL injections were not found to be accurate (up to 38% 
difference).  Final yields could be determined by isolating the products from the reaction 
mixture and were not based on masses obtained from a calibration curve. The area percentage 
results also indicated the presence of unwanted by-products which influenced the area 
percentage obtained for the product and starting material.  The detection of unwanted by-
products was crucial as the technology being developed should result in limited by-products 
as the final product down-stream processing should not be complicated by unwanted products 
requiring sophisticated separating techniques on large scale.  UPLC-MS was also used to 
determine the accurate masses of the compounds to confirm the identities of the different 
compounds.  A typical result of the separation of the compounds on UPLC-MS is shown in 
Figure 18.   
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Figure 18: Chromatograms showing ambradiol (left) and (-) ambrafuran (right) measured by UPLC-MS 
 
The chromatograms in Figure 18 above show the ambradiol and ambrafuran compounds 
being confirmed and separated by UPLC-MS. 
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4.2 CONVERSION OF SCLAREOL TO INTERMEDIATE AMBRADIOL 
In the original patent by Farbood and Willis (1989) the conversion of sclareol to an 
intermediate diol using H. roseoniger was described.  The methods used in this patent was 
used a base case and further optimisations were done as reported in the thesis.  
4.2.1 Determining the growth of H. roseoniger  
H. roseoniger from working cell bank as explained in 3.3.2 was used in this experiment for 
determining the growth phase of the organism. H. roseoniger (1 mL) was inoculated into 100 
mL PDB and the samples were collected at 0, 8, 32, 48, 56 and 72 hours respectively. Figure 
19 shows the growth phase of H. roseoniger optical density measured at 600 nm wavelength 
in three flasks. 
 
Figure 19: Results showing the growth curve for H. roseoniger in PDB media 
The growth of the H. roseoniger started slowly as it took 8 hours to reach the optical density 
of 0.19 in flask 1 and 2 as seen in Figure 19.  Cells in flask 3 show a rapid increase compared 
to flask 1 & 2 as it has reached the optical density of 0.48 in 8 hours. The microorganism 
took 24 hours to reach the stationary point as demonstrated by cells in flask 1 and 2. It was 
observed under the microscope that the cells in flask 3 were contaminated and it was 
confirmed by the decrease in optical density at 24 hours compared to cells in flask 1 and 2 as 
seen in Figure 19. A slight increase of cell growth in flask 3 at 24-32 hours proved that the 
cells may have been contaminated by other cells which inhibited the normal growth of H. 
roseoniger compared to cells in flask 1 and 2, as seen in Figure 19. It is imperative that the 
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cell cultures used in the experiments are pure and not contaminated as it may result in other 
products being produced by the contaminated microorganism. 
4.2.2 Examination for conversion of sclareol to ambradiol using H. roseoniger pre-
inoculums of 24, 48 and 72 hours at 25˚C without transferring to fresh medium 
The starting material, sclareol, can be converted to the intermediate diol, ambradiol.  The 
production of the ambradiol compound was examined by using H. roseoniger pre-inoculum 
cells grown for 24, 48 and 72 hours respectively. The pre-inocula were produced in 100 mL 
PDB medium and following the growth for 24, 48 or 72 hours, 20 mg of the sclareol was 
added to the same medium for induction of the microorganism.  After 3 days of induction, the 
sclareol with Tween 80 were added and the growth followed 7 days and the results are 
presented in Table 1 below.  
 
Table 1: The area percentage yield of ambradiol in potato dextrose media from 24, 48 and 72 hours pre-inoculums 
Days of reaction Pre-inoculum (hours) Temperature (˚C) Yield of ambradiol 
(Area %) 
7 24 25 9.1 
7 48 25 24.7 
7 72 25 33.2 
The yield of ambradiol was less than 50% in each reaction as shown in Table 2. H. 
roseoniger for the pre-inoculum for this experiment was grown from 1 cryovial in 100 mL of 
PDB and obviously did not give maximum growth compared to further experiments done in 
which 1 cryovial of the microorganism was grown in 25 mL of PDB.  The difference can also 
be seen in the results from the growth curve shown under section 4.2.1.  It is therefore very 
important to use the appropriate amount of cryovials per volume for maximum growth in the 
pre-inoculum.  It could also be the result of diminishing nutrients in the PDB medium as the 
original PDB medium was used to produce the pre-inoculum and then the bioconversion was 
continued in the same PDB while in all other experiments, the pre-inoculum was prepared in 
a PDB medium and then 5 mL of the pre-inoculum was placed into fresh PDB medium for 
the bioconversion of the sclareol to the ambradiol.  This means that the transfer of 
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microorganism to a fresh medium enhance the biotransformation of sclareol to ambradiol due 
to sufficient available nutrient.  
4.2.3 An investigation for ambradiol production using H. roseoniger from 24, 48 and 72 
hours pre-inoculums at 25˚C by transferring the pre-inoculum to fresh medium 
This experiment described in 3.3.4 was to test the production of ambradiol from H. 
roseoniger pre-inoculum from a 1 mL cryovial for 24, 48 and 72 hours respectively in PDB 
(100 mL) at 25˚C. In this experiment, 5 mL each of pre-inoculum was transferred into a fresh 
(100 mL) PDB media and induced with 20 mg substrate (sclareol) for 3 days. The sclareol (1 
g) and Tween-80 (1 mL) were added to the media and allowed to react for 7 days. The aim 
was to determine the optimum time for the pre-inoculum required for the biotransformation 
of the substrate (sclareol) to the intermediate diol. This investigation was also an attempt to 
demonstrate the effectiveness of the H. roseoniger in fresh media in comparison to the other 
experiment depicted in the previous section 4.2.2 above. The results for this investigation are 
listed in Table 2 below. 
 
Table 2: Ambradiol area percentage yield obtained from reactions of 24, 48 and 72 hours with H. roseoniger pre-
inoculums in fresh potato dextrose broth media at 25˚C 
Pre-inoculums (hours) Temperature (˚C) Yield of ambradiol (%) 
24 25 3.8 
48 25 6.6 
72 25 37.7 
The biotransformation of sclareol to ambradiol with cells from 24 and 48 hours pre-
inoculums were very low, both yielding less than 10% of ambradiol. The yield of 37.7% 
resulting from the 72 hour pre-inoculum as shown in Table 3 proved that 1 mL H. roseoniger 
from a cryovial in 100 mL PDB was not able to reach a specific biomass for optimum 
biotransformation of sclareol to ambradiol. This further suggested that biotransformation of 
sclareol to ambradiol by H. roseoniger was achievable due to more biomass produced from 
pre-inoculum and that the pre-inoculum should be grown for at least 72 hours.  The increase 
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of the cryovial volume per volume of PDB was confirmed by the results from section 4.2.1 
and for this reason all other experiments were done with pre-inoculums produced from 1 
cryovial (1 mL) of H. roseoniger in 25 mL of PDB. 
4.2.4 Testing different media for conversion of sclareol to ambradiol 
Different aqueous nutrient media were tested namely. (1). 0.1% NH4NO3 (w/v), 0.1% 
KH2PO4 (w/v), 0.05% MgSO4.7H2O (w/v) and Yeast extract; (2). 0.1% NH4NO3 (w/v), 0.1% 
KH2PO4 (w/v), 0.05% MgSO4.7H2O (w/v), 0.5% (D+) Glucose (w/v) and Yeast extract; and 
(3). Difco™ Yeast nitrogen base without amino acids with 0.1% NH4NO3 (w/v). Figure 20 
represents ambradiol area percentage yield obtained by GC from different media in terms of 
the ambradiol being produced with time.  
 
Figure 20: Area percentage yield of ambradiol obtained from different media using H. roseoniger 
Figure legend:  The media used are as follows; Media 1: 0.1% NH4NO3 (w/v), 0.1% KH2PO4 (w/v), 0.05% 
MgSO4.7H2O (w/v) and Yeast extract; Media 2: 0.1% NH4NO3  (w/v), 0.1% KH2PO4 (w/v), 0.05% MgSO4.7H2O (w/v), 
0.5% (D+) Glucose (w/v) and Yeast extract; Media 3: Difco™ Yeast nitrogen base without amino acids with 0.1% 
NH4NO3  (w/v) 
All data points were average values of triplicates (n=3) readings with standard deviations (±SD) shown. 
The point converging at day 7 illustrated that the conversion rate was equivalent in all the 
media while medium 1 was initially faster and medium 2 had an initial lag phase. A new 
unidentified compound formed during the reaction which was unacceptable as it would have 
an influence on the final conversion of ambradiol to (-) ambrafuran. This unknown compound 
constitutes between 6 – 8% by reducing the area percentage of ambradiol.   Furthermore in all 
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the media tested, sclareol was not entirely converted. media 3 which showed an increase in 
ambradiol production purity on the final day of the reaction and eventually yielded 87.69% 
while the other media had a slight increase from the point of convergence to both yield 
82.64%. Farbood and Willis, (1989) used similar type of the media without yeast extract and 
dextrose and reported to have obtained 100% purity of ambradiol by GLC after 
recrystallization.  The aim of the current work is “however” to obtain the ambradiol without 
unwanted by-products.  If however by-products cannot be eliminated during scale-up of the 
technology, recrystallization will have to be considered. This suggests that ambradiol should 
undergo purification after biotransformation. The nutrient media containing glucose (media 
2) showed high efficacy for ambradiol production but the product may require purification 
before the final cyclodehydration. 
4.2.5 Recrystallization of ambradiol 
Crude extracts were isolated by ethyl acetate in a reaction for ambradiol production which 
was carried out in NH4NO3 0.1 g, 0.1 g KH2PO4, 0.05 g MgSO4.7H2O, 0.5 g Dextrose and 0.2 
g Yeast extract media as mentioned in the method section 3.3.6. The 3 g of starting material 
(sclareol) was available by combining material from the reaction done in triplicate. In this 
experiment, ambradiol was recrystallized using ethyl acetate and hexane solvents and the 
method was detailed in section 3.3.6. The aim of this experiment was to recrystallize and 
determine the purity and amount of ambradiol produce during the reaction. The results for 
this experiment are detailed in Table 3 below. 
 
Table 3: Total yield of ambradiol recrystallized and from NH4NO3 0.1 g, 0.1 g KH2PO4, 0.05 g MgSO4.7H2O, 0.5 g 
Dextrose and 0.2 g Yeast extract media 
Mass of crude 
extracts (g) 
Mass of 
recrystallized diol (g) 
Area % of ambradiol 
in crude extracts 
Area % of 
recrystallized diol 
2.28 1.51 87.51 95.85 
The area percentage of ambradiol increased from 87.51% to 95.85% after recrystallization 
and the isolated crude extracts yield of 2.28 g resulted to 1.51 g as seen in Table 3. The 
unknown compound was observed which eluted close to ambradiol and constituted 8.63%. 
Sclareol was not completely converted in the reaction and 3.86% remained. After 
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recrystallization, sclareol was completely eliminated while the unknown compound was 
reduced to 4.15%.  Farbood and Willis, (1989) used similar type of the media without 
dextrose and obtained 2.22 g ambradiol from 3 g sclareol, the sclareol was reported to have 
been recrystallized using hexane solvent, pulverized and passed through 50-sieve before 
undergoing biotransformation and the diol was reportedly confirmed with NMR 
spectroscopy. The purity of ambradiol was not determined in this case by Farbood and Willis. 
These results show 2% difference to that of Farbood and Willis in terms of the crude extracts 
obtained which was also found to be ambradiol with impurities by GC. This may suggest that 
recrystallization of ambradiol might be considered and that further purification techniques 
may be employed to improve the purity of ambradiol.  
4.2.6 Determining cell biomass of H. roseoniger in different medium at different 
conditions for biotransformation of sclareol to ambradiol 
Growing H. roseoniger at different temperatures and subjecting it to the biotransformation 
under different conditions such as doing the reaction in buffer and in medium was to 
determine the suitable conditions for both growth and conversion of sclareol to the 
intermediate ambradiol.  
(i). Biotransformation of sclareol in 1 mM sodium phosphate buffer pH 7.2 
The biotransformation of sclareol in 1 mM sodium phosphate buffer was to test whether the 
H. roseoniger would be capable to perform the biotransformation of sclareol to the 
intermediate ambradiol in a buffer instead of actively growing microorganism. The 
microorganism was initially grown in the different media as in the method section 3.3.7 for 3 
days and then harvested.  The harvested cells were placed in phosphate buffer and the 
sclareol added in the presence of Tween 80. The production of ambradiol was monitored up 
to 7 days. The results in Figure 21-24 show the production of ambradiol from the harvested 
cells of H. roseoniger in the buffer.  
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Figure 21: Area percentage yield of ambradiol produced by H. roseoniger harvested from different media at 20˚C in 1 
mM sodium phosphate buffer 
Figure legend: The media in which cells were harvested is as follows; - PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O. 
H. roseoniger cells harvested from YNBG at 20˚C show a gradual increase in ambradiol 
productivity from day 1 until day 5 and began to decrease towards the end of reaction. The 
biotransformation of sclareol was not complete at the end of reaction. The resulting unknown 
compound, which cannot be identified with certainty using LC-MS, but have a similar 
structure to ambradiol and eluting next to ambradiol had increased with time. Cells from PDB 
also showed moderate activity on production of ambradiol in buffer at 20˚C, as seen in Figure 
21 above. The results “therefore” indicate that at the chosen temperature of 20°C, the 
biotransformation does not proceed to completion in buffer and the results also indicate that 
the medium used for initial growth does play a role during the transformation reaction. 
 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8
A
re
a 
p
e
rc
e
n
ta
ge
 (
%
) 
Days 
PDB YNBG YNBaa YEGN
52 
 
 
Figure 22: Area percentage yield of ambradiol produced by H. roseoniger harvested from different media at 25˚C in 1 
mM sodium phosphate buffer 
Figure legend:  The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
H. roseoniger cells harvested from PDB and YNBG and the transformation done in buffer at 
25°C showed increased potential in biotransformation of sclareol when compared to the 
results obtained at 20°C, as seen in Figure 22 above. In PDB the transformation continued up 
to day 7 and reached a conversion of approximately 66%.  A decreased yield of ambradiol 
from day 5 to the end of reaction was seen specifically for cells harvested from YNBG. This 
may be due to the formation of the unknown compound that eluted very close to ambradiol 
and had a higher yield of 44.2% than that of ambradiol at the end of reaction.  This tendency 
was also observed at 20°C as seen in Figure 21. Cells from (YNBaa) and YEGN had limited 
efficiency in the biotransformation of sclareol to ambradiol when harvested and transformed 
in buffer.   
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Figure 23: Area percentage yield of ambradiol produced from Hyphozyma roseoniger cell biomass harvested from 
different media at 28˚C in 1 mM sodium phosphate buffer  
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O   
Cells from PDB and the transformation done in buffer were effective for biotransformation 
from day 3 to 5 and decreased towards the end of reaction. The unknown compound eluting 
next to ambradiol yielding 23.6% also had an impact on the decrease in yield of ambradiol. 
This unknown compound is suggested to be the reducing factor for maximum production of 
ambradiol. The overall biotransformation of sclareol to ambradiol by H. roseoniger in buffer 
proves to be ineffective from all the media tested for initial growth. 
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Figure 24: Area percentage yield of ambradiol produced by H. roseoniger cell biomass harvested from different 
media at 30˚C in 1 mM sodium phosphate buffer 
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
Cells harvested from all the media at 30˚C and the bioconversion done in buffer were not 
effective at performing the biotransformation when compared to reactions done at 20˚C, and 
25°C.  Figure 24 showed that only cells from PDB had a moderate activity on 
biotransformation of sclareol to ambradiol by yielding at least 42.2%. These suggested that 
the H. roseoniger microorganism is dependent on the temperature and type of media for 
effective biotransformation of sclareol to ambradiol 
 (ii). Biotransformation of sclareol in Difco™ yeast nitrogen base without amino acids 
following initial growth in different media 
Biotransformation of sclareol in YNBaa and “therefore” in an actively growing state instead 
of using isolated cells in buffer as seen in the previous set of experiments and results, has 
been done before and has been reported to have yielded ≥98% of ambradiol by Steenkamp 
and Taka, (2010).  Figure 25-28 below detailed the results for ambradiol obtained using 
isolated cells in YNBaa media. 
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Figure 25: Shows the area percentage yield of ambradiol produced by H. roseoniger harvested (cell biomass) from 
different media at 20˚C in Difco™ yeast nitrogen base without amino acids 
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
The microorganism was initially grown for 3 days in the different media as seen in the legend 
of the figure and then harvested and transferred to YNBaa for the biotransformation reaction.  
Biotransformation of sclareol to ambradiol in YNBaa yielded 89.74% of the diol using cells 
harvested from YNBG at 20˚C. The sclareol was not completely converted and an unknown 
compound has also appeared close to ambradiol peak with a peak area of 5.43%. There was 
no biotransformation of sclareol from the cells harvested from other media at 20˚C as shown 
in Figure 25 above. 
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Figure 26: Shows the Area percentage yield of ambradiol produced by H. roseoniger harvested (cell biomass) from 
different media at 25˚C in Difco™ yeast nitrogen base without amino acids 
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
The previous experiment was repeated at 25°C.  Cells harvested from a pre-inoculum of 
YNBG media at 25˚C and then transferred to YNBaa, proved to be effective for ambradiol 
production as shown in Figure 26 by yielding 88.9% of the desired product. Only moderate 
biotransformation of sclareol to ambradiol occurred using cells harvested from PDB at 25˚C 
which yielded approximately 47.76% diol as seen in Figure 26 above. Cells harvested from 
YNBaa and YEGN were not effective for biotransformation in YNBaa. The unknown 
compound peak eluted close to ambradiol was regarded as a setback for the successful 
biotransformation of sclareol to ambradiol. The ambradiol formed from the cells harvested 
from the pre-inoculum in YNBG would require further purification to satisfy the 
requirements for the final conversion to (-) ambrafuran.  
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Figure 27: Demonstrates the area percentage yield of ambradiol produced by H. roseoniger harvested (cell biomass) 
from different media at 28˚C in Difco™ yeast nitrogen base without amino acids 
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
The area percentage yield of 70.56% ambradiol was obtained from cells harvested from 
YNBG and the transformation done in YNBaa which were grown at 28˚C, as seen in Figure 
27. There was 5.64% sclareol remaining after the reaction and an unidentified compound 
eluted close to ambradiol constituting 10.33% yield. The cells from other media were not 
effective for biotransformation of sclareol to ambradiol. The unidentified compound had a 
high area percentage yield 69.83% from cells in YEGN grown at 28˚C.  These results here 
indicated that the biotransformation of sclareol to ambradiol by harvested cells of H. 
roseoniger and then transferred to YNBaa for the bioconversion is not feasible.  
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Figure 28: Shows the area percentage yield of ambradiol produced by H. roseoniger harvested (cell biomass) from 
different media at 30˚C in Difco™ yeast nitrogen base without amino acids 
Figure legend: The media in which cells were harvested is as follows; PDB: Potato dextrose broth; YNBG: Difco™ 
yeast nitrogen base without amino acids with glucose; YNBaa: Difco™ yeast nitrogen base without amino acids; 
YEGN: (0.2%) yeast extract, (1%) glucose, (0.2%) NH4NO3, (0.1%)  KH2PO4 and (0.1%) MgSO4.7H2O  
The production yield of ambradiol was low from all the cells harvested from different media 
and then biotransformed in YNBaa at 30˚C, as seen in Figure 28. Overall the results from this 
experimental section indicated that harvested microorganism H. roseoniger is not effective 
for biotransformation of sclareol to ambradiol in a buffer or YNBaa. In literature, Farbood 
and Willis, (1989) reported to have obtained 99% purity of ambradiol through isolated cells 
in 30 µM phosphate buffer pH 7.2. This may be as result of buffer concentration and pH used 
to produce low yield in this case.   
4.2.7 Measuring the production of ambradiol in Difco™ yeast nitrogen base without 
amino acids & potato dextrose broth at 20˚C and 25˚C using H. roseoniger  
The objective here was to detect and contrast the production of ambradiol at two different 
temperatures as well as different media.  
Media such as yeast extract peptone and dextrose (YPD), yeast extract peptone and dextrose 
with 0.2% malt extract (YPD with Malt extract), and nutrient media were tested under different 
conditions for the conversion of sclareol to ambradiol using H. roseoniger but no conversion 
could be demonstrated and results are not shown.  
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Potato dextrose broth (PDB) and Difco™ yeast nitrogen base without amino acids were 
repeatedly tested at different temperatures and they were significantly better when compared to 
the other media. Optimization experiments were conducted using these two media. PDB and 
YNBaa were specifically tested for biotransformation of sclareol to ambradiol using H. 
roseoniger at both 20˚C and 25˚C respectively. The cells were also tested in an induced and 
non-induced form by sclareol for the production of intermediate ambradiol. The cells were pre-
inoculated in a potato dextrose broth media at 25˚C for 3 days. Figure 29-32 below represent 
the results for the production of ambradiol from the experiment conducted in method section 
3.3.8. 
i. Non-induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids (YNBaa) and potato dextrose broth (PDB) at 20˚C 
The biotransformation of sclareol to ambradiol using H. roseoniger in both PDB and YNBaa 
were tested without initial induction with the starting material (sclareol). Figure 29 & 30 
below represent the ambradiol production taken from day 1 to 10 in both YNBaa and PDB 
media at 20˚C following inoculation with the 3 day old pre-inoculum prepared in PDB. 
  
Figure 29: Area percentage yield of ambradiol from non-induced H. roseoniger cells in both Difco™ yeast nitrogen 
base without amino acids and potato dextrose broth at 20˚C 
Figure legend: the media used for ambradiol production is as follows; PDB: Potato dextrose broth; YNBaa: Difco™ 
yeast nitrogen base without amino acids All data points were average values of duplicates (n=2) readings with 
standard deviations (±SD) shown. 
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The biotransformation of sclareol started on day 3 in YNBaa and gradually increases on a 
daily basis until the end of the reaction, as shown in Figure 29 above. The area percentage 
yield of 90.7% ambradiol from YNBaa was obtained in the end. There was 0.54% area 
percentage yield of sclareol remaining at the end of reaction and the formation of the 
unknown compound eluting close to ambradiol constituted 7.33%. Biotransformation of 
sclareol in PDB began from day 8 and rapidly increased until the final day and has yielded 
94.6% ambradiol as seen in Figure 29 above. There was limited impurity of the two unknown 
compound constituting a total of 1.2% while a 2.2% of sclareol was left after the 
biotransformation in YNBaa. These results suggested that potato dextrose broth was a 
suitable media for growth of H. roseoniger as well as for biotransformation of sclareol to 
ambradiol. The temperature also plays a crucial role for growth of H. roseoniger and for 
biotransformation to take place.  
ii. Non-induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids & potato dextrose broth (PDB) at 25˚C 
This experiment was related to the one above in Figure 29 and the only difference was the 
temperature which in this case was at 25˚C. 
  
Figure 30: Area percentage yield of ambradiol from non-induced H. roseoniger cells in both Difco™ yeast nitrogen 
base without amino acids and potato dextrose broth at 25˚C 
Figure legend: the media used for ambradiol production is as follows; PDB: Potato dextrose broth; YNBaa: Difco™ 
yeast nitrogen base without amino acids All data points were average values of duplicates (n=2) readings with 
standard deviations (±SD) shown. 
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The productivity of ambradiol in YNBaa rapidly increased from day 3 to day 5 and a slight 
drop on day 6 which could be due to a sampling error. The ambradiol production began to 
gradually increase from day 7 as shown in Figure 30 and in the end 70.46% ambradiol was 
produced. Production of ambradiol started late at 20˚C and 25˚C in PDB media as shown in 
Figure 29 and 30. The area percentage yield was slightly higher at 25˚C than at 20˚C yielding 
at least 95.3% ambradiol in PDB. The unknown compound eluting close to ambradiol had an 
area percentage yield of 21.5% in YNBaa and two unknown compounds appeared in PDB 
reactions with an overall yield of 3.6%. The sclareol was not completely converted in both 
media with 1.1% remaining in PDB and 3.4% in YNBaa at 25˚C.  These results proved that 
ambradiol can be formed in PDB without H. roseoniger cells being induced. It does however 
require a longer time period before the conversion was completed.  
iii. Induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids & potato dextrose broth (PDB) media at 20˚C 
The purpose of induction was to stimulate the cells to enhance the production of ambradiol 
and reduce the lag time before production start.  Sampling was conducted from day one to 
day seven to monitor the production progress and is depicted in Figure 31 and 32 below.  
 
Figure 31:  Area percentage yield of ambradiol from induced H. roseoniger cells in both Difco™ yeast nitrogen base 
without amino acids and potato dextrose broth at 20˚C 
Figure legend: the media used for ambradiol production is as follows; PDB: Potato dextrose broth; YNBaa: Difco™ 
yeast nitrogen base without amino acids All data points were average values of duplicates (n=2) readings with 
standard deviations (±SD) shown. 
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There was a complete sclareol conversion in PDB media at the end of the reaction at day 7. 
The ambradiol productivity in PDB media shows a rapid increase from day 4 to 5 and the 
yield of 96.58% ambradiol at the end of the reaction. Small amounts of impurities were 
observed constituting 2.55% and 0.87% unknown compounds eluting just after (-) 
ambrafuran. From day 3-4, ambradiol production in YNBaa showed an increase compared to 
PDB as seen in Figure 31. The unidentified compound eluting close to ambradiol in YNBaa 
decreased the yield of ambradiol. The results demonstrate that ambradiol can be produced 
with high yield at 20˚C when H. roseoniger are induced especially in PDB media. 
iv. Induced reaction for ambradiol production in Difco™ yeast nitrogen base 
without amino acids at 25˚C  
In this experiment, the biotransformation of sclareol to ambradiol was conducted at 25˚C and 
the cells were induced. This experiment was similar to the one above (iii) but differed with 
incubation temperature. Ambradiol production was measured in area percentage from day 1-7 
as shown in Figure 32 below. 
 
Figure 32:  Area percentage yield of ambradiol from induced H. roseoniger cells in both Difco™ yeast nitrogen base 
without amino acids (YNBaa) and potato dextrose broth (PDB) at 25˚C 
Figure legend: the media used for ambradiol production is as follows; PDB: Potato dextrose broth; YNBaa: Difco™ 
yeast nitrogen base without amino acids All data points were average values of duplicates (n=2) readings with 
standard deviations (±SD) shown. 
The ambradiol production at 25˚C in PDB gave a final yield of 96.81%, as seen in Figure 32 
above. Sclareol was completely converted in day 7, however the two unknown compounds 
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were observed eluting just before the ambradiol and constituted almost 3%. Ambradiol was 
also produced in YNBaa media yielding 90.09% with an unknown compound eluting next to 
it. Overall results in this experiment suggested that H. roseoniger was capable of performing 
the biotransformation of sclareol to ambradiol under aerobic condition in an aqueous nutrient 
medium. The induction reactions showed the highest yield of ambradiol in PDB media at 
both 20˚C and 25˚C temperature compared to the non-induction. After 7 days with the non-
induced microorganism the conversion of the sclareol to ambradiol only reached 15.7% while 
it was 96.81% converted on day 7 following induction.  The non-induced conversion took 10 
days to reach a similar conversion. 
4.2.8 Testing conversion of ambradiol on a larger scale in potato dextrose broth (PDB) 
at 25˚C using H. roseoniger in an orbital shaker incubator 
This first scaled-up reaction was done in 1 L Fernbach flasks with a working volume of 700 
mL.  The purpose of this experiment was to determine the production of ambradiol in a large 
scale reaction. Table 4 below shows the production of ambradiol from a 7 day reaction in 
PDB by H. roseoniger. 
 
Table 4: The area percentage yield of ambradiol produced from a larger scale reaction in potato dextrose broth 
media by H. roseoniger 
Temperature (˚C) Standard deviations Yield of ambradiol 
(%) 
Area percentage of 
the impurities (%) 
25 1.5 96.2 3.8 
The yield of ambradiol in these results was the average values calculated from the experiment being conducted in 
triplicate (n=3) with standard deviations (±SD). 
The sclareol was totally transformed in all the flasks after 7 days reaction and the average 
yield of ambradiol was 96.2%. The impurities obtained were two unidentified compounds 
peaks with low percentage yield of 3.8% as indicated in Table 4, eluting just before and after 
the ambradiol peak at 3.552 & 4.531 retention times. These results substantiate that H. 
roseoniger was capable of transforming sclareol to ambradiol in PDB media at 25˚C at larger 
scale. It was evident that PDB can also be used as media in biotransformation of sclareol to 
ambradiol using the microorganism H. roseoniger. The production difference of ambradiol 
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between the flasks was marginal with the standard deviation of 1.5 shown in Table 4 above. 
This illustrated the consistency and reproducibility in terms of ambradiol production between 
the three flasks. 
4.2.9 Test for ambradiol production in 2 L fermentation bioreactor using H. roseoniger 
This experiment was conducted in a 2 L fermentation bioreactor at a scale of 1.2 L working 
volume at 25˚C. The pre-inoculum was grown for three days and then the microorganism (H. 
roseoniger) was induced for 3 days. The aim was to test the scalability using a fermenter 
resembling the equipment used on commercial scale and to assess the time for production. 
The following Table 5 outlined the results obtained during the experiment. 
 
Table 5:  Results for ambradiol production in area percentage yield taken at different times during fermentation 
process 
Media type  Temperature 
(˚C) 
Yield of 
ambradiol at 24 
hours (%) 
Yield of 
ambradiol at 31 
hours (%) 
Yield of 
ambradiol at 48 
hours (%) 
Potato dextrose 
broth 
25 93.0 87.7 86.7 
The ambradiol yield was high at 24 hours yielding at least 93.0% and decreased as 
fermentation process progresses as shown in the table above. Sclareol was not entirely 
converted during 24 hour and there was no any impurity at this stage. As it was close to 
completion samples were taken intermittently to determine the end point. At 31 hours, the 
ambradiol yield was 87.7% and sclareol (2.1%) was still available with the unknown 
compound peak noticed with 10.3% yield. The unknown compound eluting close to 
ambradiol was suspected to have caused the reduction due to its increasing yield. The sclareol 
was successfully converted at 48 hours and there was an increase of the unknown compound 
with a yield of 13.3% which resulted in slight decrease of ambradiol from 87.7% to 86.7% as 
shown in Table 5 above. The reaction was then stopped at 48 hours following the gradual 
reduction of ambradiol yield compared to 24 and 31 hours. The outcome of the fermentation 
indicated that biotransformation of sclareol to ambradiol was faster in a bioreactor as it 
already yielded 93% after 1 day. The reduction in yield of ambradiol with time suggested that 
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the microorganism was gradually converting the product (ambradiol) into the unidentified 
compound. 
4.3 CYCLODEHYDRATION TO PRODUCE (-) AMBRAFURAN 
Following conversion of the sclareol to ambradiol using the H. roseoniger, the final 
conversion of the ambradiol to (-) ambrafuran is required.  As discussed in the literature 
review, chemical syntheses use very harsh chemicals such as pyridine for this reaction.  
Steenkamp and Taka (2010) reported and patented the use of zeolites for the conversion of 
the intermediate diol to (-) ambrafuran. 
4.3.1 Measuring the production of (-) ambrafuran in different ratios using zeolite 
CBV320 
The work done by Steenkamp and Taka (2010) was based on the use of zeolite CBV320 
which was activated in a conventional microwave oven.  The aim of this experiment was to 
examine the ability of zeolite CBV320 at different ratios of ambradiol per zeolite and also 
reducing the solvent for production of (-) ambrafuran at room temperature. Different power 
levels of 30 W, 50 W, 70 W and 90 W were tested for activation of zeolite (1 g) in a 
conventional microwave for 1, 2 & 3 mins and found that at 70 W for 3 mins the zeolite was 
necessary to activate the zeolite to catalyses the reaction for ambradiol conversion to 
ambrafuran. The ratios of 1:5, 1:7 and 1:9 (ambradiol per zeolite) as showed in the legends in 
Figure 34 were tested and compared for zeolite CBV320’s ability to convert 5 mg of 
ambradiol and producing ambrafuran in 1 mL hexane solvent compared to the work 
previously done by Steenkamp and Taka (2010) which used 5 mg/20 mL solvent. Figure 33 
below illustrates the results obtained from each ratio. 
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Figure 33: A bar graph representing area percentage of (-) ambrafuran from different ratio using zeolite CBV320 at 
25˚C 
The results show the mean values of experiments done in triplicates (n=3) with standard deviations (±SD). 
A percentage yield of 84.03% (-) ambrafuran was obtained in a ratio of 1:9 (ambradiol per 
zeolite CBV320), as seen in Figure 33 above. Two unidentified compounds were detected 
and eluting after (-) ambrafuran in all the ratios at retention times of 3.372 and 3.545 mins 
respectively. Ambradiol was completely converted at 1:9 ratios compared to that at 1:7 and 
1:5 ratios and the two unknown compound constituting 13.32% and the other 3.57% has 
reduced the production yield of ambrafuran.  From the work done by Steenkamp and Taka, 
(2010) 98% (-) ambrafuran was obtained in a 1:9 ratio of ambradiol per zeolite CBV320 in 20 
mL hexane.  The results indicate that high amount of zeolite and high volume of solvent had 
more influence in the cyclodehydration of ambradiol to yield pure ambrafuran. This suggests 
that solvent reduction may have contributed in forming the unidentified compounds during 
the reaction.  The zeolite (15 g) used by Steenkamp and Taka (2010) was activated in a 
microwave oven for 15 mins and at 50 W power level. 
4.3.2 Determining the production of (-) ambrafuran in different solvents at 1:9 ratio 
using zeolite CBV320 
Different solvents that are considered to be acceptable for production of (-) ambrafuran were 
tested in this experiment. Ethyl acetate, Hexane, Chloroform, Dichloromethane (DCM), 1,2-
Butanediol, 1,2-Propanediol, t-Butanol, Isopropanol, Heptane, Toluene, Decane and 
Dimethylsulphoxide (DMSO) were all examined for ambradiol production and Figure 34 
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shows the production activity in area percent. The zeolite was activated in a conventional 
microwave at 70 W power level for 3 mins. Ambradiol (5 mg), 45 mg activated zeolite and 1 
mL of the solvents mentioned was used in each reaction. The purpose of this experiment was 
to identify the potential solvents to be used for the cyclodehydration of ambradiol to form 
ambrafuran and the results are demonstrated in Figure 34.  
 
Figure 34: Production of ambrafuran results in area percentage obtained from different solvents 
The results show the mean values of experiments done in duplicates (n=2) with standard deviations (±SD). 
Reactions where t-Butanol, 1,2-propanediol, isopropanol, ethyl acetate, chloroform, 
Dimethylsulphoxide (DMSO) and 1,2-Butanediol solvents used, a low conversion of 
ambradiol was observed with a low yield of (-) ambrafuran as seen in Figure 34.  The highest 
yield of (-) ambrafuran amongst all the solvents was in hexane, yielding 82.3%. Ambradiol 
conversion was complete in hexane, decane and heptane solvents with two unknown by-
products forming after ambrafuran peak. Two unknown compounds before (-) ambrafuran 
peak eluted in a reaction involving decane with an overall yield of 2.3%. These results show a 
slight decrease by approximately 2% as compared to the results in Figure 33 at 1:9 ratio in 
hexane. This could be the effect of inconsistent injection volume as a result of manual 
injection in the GC. The overall results suggest that hexane was more effective than other 
solvents; however decane and heptane also proved to be valuable for the cyclodehydration of 
ambradiol to produce (-) ambrafuran. 
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4.3.3 Different zeolites for the determination of (-) ambrafuran production 
Different zeolites such as CBV500-X16, CBV8062, CBV100, CBV320 found in-house from 
different suppliers as well as aluminium were tested for their ability to perform the 
cyclodehydration of ambradiol to produce (-) ambrafuran in hexane solvent. In this 
experiment, a ratio of 1:5 ambradiol (20 mg) per zeolite (100 mg) was used in 1 mL hexane 
solvent and the reaction took place at 25°C for 6 hours. The aim was to identify an effective 
zeolite for conversion of ambradiol to (-) ambrafuran and the method was explained in 3.4.3. 
Figure 35 below show the results for ambrafuran produced from each zeolites and aluminium. 
 
Figure 35: Show the production yield of (-) ambrafuran in area percentage from different zeolites 
Figure legend:  CBV100, CBV500-16, CBV8062 and CBV320 demonstrate the identity of each zeolite that was tested 
for production of ambrafuran. Alumin represent aluminium being tested for ambrafuran production in the legend 
entry.  
The results show the mean values of experiments done in duplicate (n=2) with standard deviations (±SD). 
Zeolite CBV320 yielded at least 41.15% (-) ambrafuran and 33.25% sclareol left after the 
reaction. The rest of the zeolites all yielded less than 10% (-) ambrafuran as seen in Figure 35 
above. A number of unknown compounds formed constituting 25.6% in zeolite CBV320 and 
the results were related to the previous experiment in 4.3.1 for 1:5 ratio. Steenkamp and 
Taka, (2010) demonstrated that (-) ambrafuran was produced at 1:6 ratio at 25°C for 4-6 
hours, however this was done in high volume of solvent. It can be suggested from Steenkamp 
and Taka that low volume of solvent had an impact on the low yield of ambrafuran. 
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4.3.4 Evaluation of (-) ambrafuran production in a water bath sonicator, magnetic 
stirrer plate and orbital shaker incubator 
Equipment such as a sonicator water bath, magnetic stirrer plate and orbital shaker were used 
for running a reaction for (-) ambrafuran production in section 3.4.4. Zeolite CBV320 was 
used at 1:3 ratio in 1 mL hexane. Reactions on a magnetic stirrer plate and in an orbital 
shaker incubator were carried out at 25°C for 4 hours. It was difficult to control the 
temperature in the water bath sonicator as the water became hot which resulted in the 
evaporation of the solvent in the reaction. Therefore the experiment in the water bath 
sonicator was conducted for 3 hours while the hot water in the sonicator was replaced with 
fresh room temperature water every hour. Figure 36 below show the bar graph for 
ambrafuran production from each instrument. The purpose was to test for (-) ambrafuran 
production in the equipment mentioned and at low ratio of substrate to zeolite. 
 
Figure 36: The results for (-) ambrafuran production from a reaction in a sonicator water bath, magnetic stirrer 
plate and orbital shaker incubator 
Figure legend: ORB shaker: represent the orbital shaker incubator; Stirrer: represent the magnetic stirrer plate; 
Sonicator: For sonicator water bath. 
The results show the mean values of experiments done in triplicates (n=3) with standard deviations (±SD). 
The conversion of ambradiol was complete in a water bath sonicator reaction and produced 
72.16% (-) ambrafuran with two unidentified compounds being formed eluting after the (-) 
ambrafuran peak yielding 15.30% and 12.54% respectively. These compounds could not be 
identified using the GC as no MS was available with this equipment.  The LC-MS could also 
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not conclusively determine the identity of these two contaminating compounds.  In a reaction 
with both a magnetic stirrer plate and orbital shaker incubator, the ambradiol was not entirely 
converted at 25°C and the yield of (-) ambrafuran was 26.59% and 36.69% as seen in Figure 
36. Production of (-) ambrafuran in a water bath sonicator has not been reported before, and 
the increased temperature in the water bath or the improvement of mixing experienced in the 
sonicator may have influenced the conversion. The results from water bath sonicator show 
that (-) ambrafuran can be produced in a small ratio of ambradiol per zeolite and in low 
volume of solvent. 
4.3.5 Measuring the production of (-) ambrafuran in a water bath sonicator using new 
zeolites 
Two new zeolites were received as a generous gift from Zeolyst International and their 
identities were CFG-1 and ZD0614. They were both tested for the cyclodehydration process 
of ambradiol to produce (-) ambrafuran. The reaction was conducted in a water bath sonicator 
and the zeolites were in an activated and non-activated form. Activation of zeolites was 
conducted in a conventional microwave at power level of 70 W for 3 mins. The 1:3 and 1:6 
ratios were used and the experiment was conducted for 3.5 hours. The main purpose for this 
experiment was to determine the ability of the new zeolites for (-) ambrafuran production. 
Figure 37 indicates the production of (-) ambrafuran for 1:3 ratio from both activated and 
non-activated new zeolites. The results for 1:6 ratio are not presented as there were multiple 
compounds eluting in a sequence with no (-) ambrafuran from both zeolites.  
 
Figure 37: Shows the results for (-) ambrafuran production by zeolites CFG-1 and ZD0614 in an activated and non-
activated form for 1:3 ratio 
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Figure legends: ACT-CFG-1: Activated zeolite CFG-1; ACT ZD0614: Activated zeolite ZD06014; N-ACT-CFG-1: 
Non-activated zeolite CFG-1: N-ACT-ZD0614: Non-activated zeolite ZD06014. 
 The results show the mean values of experiments done in duplicates (n=2) with standard deviations (±SD). 
There was no (-) ambrafuran production at 1:6 ratio for both zeolites from activated and non-
activated as explained above. Zeolite CFG-1 formed 86.5% (-) ambrafuran from a non-
activated form at 1:3 ratio as seen in Figure 37 and ambradiol was completely transformed 
while two unknown compounds were observed. These unknown compounds constituted 9.3% 
and 4.2%. In a reaction with activated zeolite CFG-1, the yield of (-) ambrafuran was 68% 
and 5.4% ambradiol left after reaction. The two unknown compounds were observed in all 
the reactions. Ambradiol was not entirely converted by zeolite ZD06014 in both activated and 
non-activated form. The area percentages for ambradiol remaining in an activated and non-
activated ZD06014 were 12.1% and 11.8%. Both zeolites were able to produce (-) 
ambrafuran at 1:3 ratio in a non-activated and an activated form. Zeolite CFG-1 was effective 
in a non-activated form compared to zeolites CBV320 and ZD06014 at 1:3 as seen in Figure 
36 and 37. These results shows that the new zeolites CFG-1 and ZD06014 are able to perform 
the cyclodehydration of ambradiol to (-) ambrafuran without being activated compared to 
zeolite CBV320 which require activation before use. Both new zeolites were not able to 
produce ambrafuran at 1:6 ratio compared to CBV320 which was reported to have produced 
±98% (-) ambrafuran at 25°C for 4-24 hours (Steenkamp and Taka, 2010; Carey, 2013b) 
4.3.6 Conversion of ambradiol to (-) ambrafuran at different temperatures into an 
orbital shaker 
The (-) ambrafuran production reactions were carried out using orbital shaker. The ratio of 
intermediate ambradiol and zeolites was 1:3 in 1 mL of hexane. Zeolites CBV320, CFG-1 
and ZD0614 were used in this experiment. Zeolite CBV320 was activated at 70 W for 3 min 
in a microwave while the others were used without being activated. The aim was to determine 
the suitable condition and to find the effective zeolite for (-) ambrafuran production. Figure 
38 demonstrates the production of ambrafuran at different temperatures by the three different 
zeolite mentioned above. 
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Figure 38: Illustrates the production of (-) ambrafuran at 50˚C, 60˚C and 70˚C by zeolites CBV30, CFG-1 and 
ZD06014 
The results show the mean values of experiments done in triplicates (n=3) with standard deviations (±SD).  
Temperatures of 30˚C, 35˚C, 40˚C and 45˚C were also done for the same 1:3 ratio using the 
three mentioned zeolites and (-) ambrafuran production was not achieved and therefore 
results are not shown. Ambradiol conversion was complete at 60˚C & 70˚C for each zeolite 
and the highest yield of (-) ambrafuran was obtained at 60˚C with a yield of 86.7% for CFG-1 
zeolite as seen in Figure 38. Two unknown compounds were observed eluting just after the (-
) ambrafuran compound with the combined yield of 13.3%.  At 70˚C, zeolite CBV320 
produced (-) ambrafuran with the highest yield of 77.4% and the lowest yield of 61.4% was 
produced by a zeolite CFG-1. All the zeolites were not able to completely transform 
ambradiol at 50˚C and CFG-1 zeolite again produced the lowest yield of (-) ambrafuran. The 
results indicated that CFG-1 was an effective zeolite for the transformation of ambradiol to (-
) ambrafuran at 60˚C amongst the others by producing the highest yield.  
4.3.7 Determination of (-) ambrafuran production at low ratios using zeolites CFG-1, 
ZD0614 and CBV320 at 60˚C in orbital shaker incubator 
The lower ratios at 1:1 and 1:2 ambradiol per zeolite were tested in this experiment for the 
production of (-) ambrafuran in an orbital shaker incubator at 60˚C for a period of 7 hours. 
Zeolite CBV320 was activated as described before while the other two zeolites were used in a 
non-activated form. The aim of this test was to investigate whether the zeolites used are able 
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to transform ambradiol to (-) ambrafuran at lower ratios and Figure 39 shows the results 
obtained. 
 
Figure 39: Results for ratios of 1:1 and 1:2 tested for production of (-) ambrafuran using zeolites CFG-1, ZD0614 and 
CBV320 at 60˚C 
The legends entry represents the zeolites identity with the ratios used (ambradiol per zeolite). 
The transformation of ambradiol was completed in all zeolites at 1:2 ratios and the highest 
yield of (-) ambrafuran was 84.81% obtained from the CFG-1 zeolite, while there was two 
unidentified peaks eluting at retention times of 3.372 and 3.545 mins. Zeolite ZD0614 formed 
an unidentified compound peak which eluted close to (-) ambrafuran and CBV320 zeolite 
yielded at least 74.6% (-) ambrafuran despite the two unidentified peaks. Ambradiol 
transformation was not complete in a 1:1 ratio for all the zeolites and the unidentified 
compounds peaks eluting at similar retention times as in 1:2 ratio were also noticed. Similar 
types of reaction were carried out for 24 hours and the results (not shown) were not much 
different from these. The two unidentified compounds peaks eluting at retention times of 
3.372 and 3.545 were regarded as a major drawback as they reduced the productive yield of (-
) ambrafuran.  
4.3.8 Measuring the increased concentration of ambradiol for (-) ambrafuran 
production 
The concentration of ambradiol was increase from 5 mg/mL to 100 mg/mL and zeolite CFG 
was used to catalyses the reaction. The aim was to determine the production of (-) ambrafuran 
at high concentration of the intermediate diol. The reaction was conducted at 60˚C for 7 hours 
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and the method was detailed in section 3.4.8 and Table 6 below shows the results for (-) 
ambrafuran produced. 
 
Table 6: Illustrates the production of (-) ambrafuran at high concentration of intermediate diol in area percentage 
yield 
Area % yield of (-) 
ambrafuran 
Area % of unknown 
compounds 
Standard deviations of (-) 
ambrafuran  
85.0 15.0 0.36 
The yields of (-) ambrafuran in these results are the average values of experiments conducted in triplicate (n=3). 
Ambradiol was successfully converted; however the two unidentified compounds limited the 
production of (-) ambrafuran to 85% as seen in Table 6. The triplicate reaction showed a 
good variation as the standard deviation was 0.36. The results show a slight difference 
compared to the low concentration of ambradiol used in previous experiment in 4.3.7 which 
yielded 84.81%. This suggests that (-) ambrafuran may be produced at high ambradiol 
concentration at 1:2 ratio by zeolite CFG-1, however it may requires to undergo purification.   
4.3.9 Determination of the recycled zeolite CFG-1 for production of (-) ambrafuran 
The recycled zeolite CFG was tested for (-) ambrafuran production in this experiment at 1:2 
ratios (10 mg diol and 20 mg zeolite) in 1 mL hexane. The zeolite was washed with ethanol 
and dried at 100˚C for overnight before used. Production of (-) ambrafuran was analysed by 
GC and the results are presented in Table 7 below. The purpose of the experiment was to 
determine the effectiveness of the recycled zeolite for production of (-) ambrafuran compared 
to the fresh zeolite. 
 
Table 7: Demonstrates (-) ambrafuran production by recycled zeolite CFG-1 in area percentage 
Area % yield of (-) 
ambrafuran 
Area % of unknown 
compounds 
Standard deviations of (-) 
ambrafuran 
82.2 17.8 0.8 
The area percentage yields of (-) ambrafuran are average values of the experiment conducted in triplicate (n=3). 
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The recycled zeolite CFG-1 was able to completely convert ambradiol but the two unknown 
compounds were appeared as in the previous experiments. The percentage yield of 82.2% (-) 
ambrafuran was obtained from the recycled zeolite CFG-1 as seen in Table 7. The unknown 
compounds inhibited the full production of ambrafuran by 17.8%. These results show a slight 
decrease of almost 3% compared to the fresh zeolite reaction. This proves that the recycled 
zeolite may be re-used for the production of (-) ambrafuran and purification may be required 
for high purity. 
4.3.10 Determining the production of (-) ambrafuran from impure ambradiol using 
zeolite CFG-1, CBV320 and ZD06014 
Ambradiol with unknown compounds eluting close to it was used in this experiment for (-) 
ambrafuran production. Zeolites CFG-1, CBV320 and ZD06014 were all tested with the 
contaminated intermediate ambradiol at 1:2 ratio in 1 mL (10 mg diol and 20 mg of each 
zeolites) as in previous experiment. Results are demonstrated in Table 8 below. 
 
Table 8: : Show results for (-) ambrafuran production from contaminated intermediate diol by zeolite CFG-1, 
CBV320 and ZD06014 
Area % of (-) ambrafuran 
from CFG-1 
Area % of (-) ambrafuran 
from CBV320 
Area % of (-) ambrafuran 
from ZD06014 
52.1 33.8 31.9 
The area percentage yields of (-) ambrafuran are average values of the experiment conducted in duplicate (n=2). 
Zeolite CFG-1 proved to be the most effective compared to CBV320 and ZD06014 by 
yielding 52.1% (-) ambrafuran in an impure ambradiol reaction. The impure ambradiol was 
completely converted at zeolite CFG-1, however the unidentified compound eluting close to 
ambradiol remained with 24.2% yield. The two unknown compounds that were reported in 
previous experiments were also observed and contributed 16.3%. There were three additional 
compounds observed with each contributing ≤ 3%, see appendix in Figure 41. This was also 
observed in a CBV320 reaction, however the unidentified compound eluting close to 
ambradiol was 42.4% and the commonly two unknown compound with a combined yield of 
16.8%. In ZD06014 reaction, ambradiol was not completely converted with 3.8% left while 
the unidentified compound eluting close to it contributed 41.5%. Lots of unknown 
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compounds were observed with the yields of ≤ 2% and the common two identified 
compounds contributing the total of 12%, see appendix in Figure 42. These results indicate 
that a pure ambradiol may be required for the cyclodehydration step to produce (-) 
ambrafuran with high purity. 
4.3.11 Determining the effect of magnesium sulphate (MgSO4) anhydrous and 
molecular sieves for production of (-) ambrafuran at 60˚C 
During the reduction of the zeolite ratio, two unwanted peaks formed in the production of (-) 
ambrafuran and the hypothesis was that water which formed during the cyclodehydration 
may cause this.  The use of the low ratios of zeolite to substrate compared to the initial work 
by Steenkamp and Taka (2010) might not absorb the water formed, giving rise to the 
unwanted compounds.  This warranted the addition of a small amount of magnesium sulphate 
anhydrous or molecular sieves in the reaction. In this experiment, we demonstrated how the 
addition of magnesium sulphate anhydrous and molecular sieves can enhance the purity of 
ambrox produced. The purpose of this experiment was to trap the formed water which is 
produced as a result of the cyclodehydration to increase the purity of (-) ambrafuran and 
Table 9 below outlined the outcome of the experiment.  
 
Table 9: The percentage yield of (-) ambrafuran from a reaction with addition of non-activated magnesium sulphate 
anhydrous and molecular sieves 
Reaction with 
added: 
Reaction 
temperature (˚C) 
Total reaction 
time (Hours) 
Yield of (-) 
ambrafuran (%) 
Area 
percentage of 
the two 
unknown 
peaks (%) 
MgSO4 
anhydrous 
60 7 87.9 12.1 
Molecular sieves 60 7 87.9 12.1 
The yields of (-) ambrafuran in these results are the average values of experiments conducted in triplicate (n=3). 
There was a slight decrease of yield for the unidentified compounds from both reactions with 
either magnesium sulphate anhydrous and molecular sieves. This confirmed that the 
77 
 
unidentified compounds were formed due to the water effect from the cyclodehydration. The 
area percentage yield of (-) ambrafuran was similar for both reactions and yielded at least 
87.9% from the 84.81% in a reaction without the adsorbed as seen in Figure 39 above. This 
proved that both magnesium sulphate anhydrous and molecular sieves may contribute in 
trapping off water from the cyclodehydration reaction. The overall reduced yield of 
unidentified compounds was almost 3% from both reactions with magnesium sulphate and/or 
molecular sieves and warranted further investigation. 
4.3.12 Examining (-) ambrafuran production using anhydrous activated MgSO4 & 
molecular sieves in combination with zeolite CFG-1 
The reaction for production of (-) ambrafuran involving the magnesium sulphate anhydrous 
and molecular sieves was to minimise water content in the reaction. The magnesium sulphate 
and molecular sieves were activated in an oven before addition of the reaction. Molecular 
sieves spheres were crushed into fine powder form before activated as mentioned in method 
section 3.4.12. The results for production of (-) ambrafuran are shown in Table 10 below.  
 
Table 10: The percentage yield of (-) ambrafuran from a reaction with addition of activated magnesium sulphate 
anhydrous and molecular sieves 
Reaction with 
added: 
Reaction 
temperature (˚C) 
Total reaction 
time (Hours) 
Yield of (-) 
ambrafuran (%) 
Area 
percentage of 
the two 
unknown 
peaks (%) 
Activated 
MgSO4 
anhydrous 
60 7 90.7 9.3 
Activated 
molecular sieves 
60 7 90.6 9.4 
The yields of (-) ambrafuran in these results are the average values of experiments conducted in triplicate (n=3). 
The (-) ambrafuran yield increased to ≥90% in both reactions containing dried magnesium 
sulphate anhydrous and molecular sieves respectively. The unknown compounds were not 
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completely separated during the reaction. These results suggest that either magnesium 
sulphate anhydrous and/or molecular sieves absorbed water that was suspected to have been 
the cause of forming the unknown compounds. The ambradiol was successfully transformed. 
4.3.13 Addition of dried MgSO4 anhydrous in a test reaction for (-) ambrafuran 
production by zeolite CFG-1 at 60˚C 
The amount of dried magnesium sulphate anhydrous was increased in this experiment and the 
activation time was extended to 24 hours. The intention of this investigation was to absorb 
more water coming from the cyclodehydration and to eliminate the formation of the unknown 
compounds from the process for production of (-) ambrafuran. Table 11 illustrates the yield 
of ambrafuran obtained during the experiment.  
 
Table 11: The results of (-) ambrafuran produced from a test reaction with added magnesium sulphate anhydrous 
activated for 24 hours at 100˚C 
Reaction with 
added: (0.1 g) 
Reaction 
temperature 
(˚C) 
Total 
reaction time 
(Hours) 
Yield of 
ambrafuran 
(%) 
Area percentage of the 
two unknown 
compounds (%) 
Activated 
magnesium 
sulphate 
anhydrous 
60 7 92.6 7.4 
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These results are presented by the average values of experiments conducted in triplicates (n=3). 
The unknown compounds were very difficult to completely eliminate and their combined 
yield was 7.4%. The (-) ambrafuran yield was increased gradually and still required some 
treatment to be complete pure, see appendix Figure 44. This result implied that more 
magnesium sulphate anhydrous needed to be added into the reaction for actual reduction of 
the unidentified compounds. The unfortunate thing is that these unknown compounds were 
not reported in studies by Steenkamp and Taka (2010) and Carey (2013). Steenkamp and 
Taka, (2010) have produced (-) ambrafuran with the highest yield of 98% and this might be 
as a results of higher amounts of zeolite used which could had absorb more water during the 
reaction. 
  
80 
 
5. CONCLUSION 
The aim of the overall project was to develop technology for a client, Teubes cc for the 
commercial production of (-) ambrafuran.  An initial two-step process was developed by 
Steenkamp and Taka (2010) and patented.  The downside of the process was the use of a high 
ratio of zeolite to substrate as well as the volume of hexane required.  This two-step patented 
method was a significant improvement on the current commercial production of (-) 
ambrafuran which is done in at least 8 steps and require very harsh chemicals and elevated 
temperatures.  The use of pyridine in the last step during current commercial production has 
an influence on the final fragrance and has been overcome by the use of zeolites in the new 
patented process.  Optimisation of the process which included testing different new zeolites 
was necessary to give a commercially viable process. 
Conversion of sclareol to intermediate ambradiol using microorganism H. roseoniger was 
successfully achieved in a potato dextrose media following several optimisation experiments. 
This intermediate ambradiol served as the starting material for production of (-) ambrafuran 
with the use of zeolite.  Two unwanted products formed during the fermentation step using 
PDB as the medium for the conversion of sclareol to ambradiol. This impure ambradiol 
product was used with zeolites to determine if it has an influence on the final (-) ambrafuran, 
but resulted in new unwanted compounds. A downstream method was also tested to separate 
unreacted sclareol from ambradiol should a large scale run not go to completion.  It was 
possible by extracting the reaction mixture with ethyl acetate followed by hexane to separate 
the substrate from the product.   Production of ambradiol was further scaled-up in a 
fermentation bioreactor and the yield was 93% at 24 hours of reaction. This will be a 
significant improvement in the technology as the complete biotransformation of sclareol to 
ambradiol was achieved in 13 days as opposed to the previously achieved 16 days.     
Following the production of ambradiol from sclareol in a single biotransformation reaction 
using H. roseoniger compared to the 7 steps required by chemical synthesis of the 
intermediate diol, the diol has to be converted to the (-) ambrafuran.  The previous work by 
Steenkamp and Taka (2010) identified the use of a zeolite, CBV320 which required initial 
activation for this final conversion. 
Two new zeolites (CFG-1 and ZD06041) were identified which did not require activation 
before use and the ratio of substrate per zeolite was reduced. The most effective zeolite was 
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CFG-1. The yield of two unknown compounds formed during the process for production of (-
) ambrafuran was reduced by approximately 8% through the addition of activated magnesium 
sulphate anhydrous and molecular sieves respectively. Further investigation such as addition 
of higher concentrations of magnesium sulphate, recrystallization and small increases in the 
zeolite concentration may be warranted to achieve high purity of (-) ambrafuran and 
eventually eliminating the unknown compounds.  The work also illustrated that higher 
concentrations (more than 5 mg/mL and up to 100 mg/mL) can be converted successfully.  
This will also contribute to the feasibility of the technology as it resulted in a significant 
reduction of the volume of hexane required.  Lower volumes of solvent will be a positive 
outcome on commercial scale. 
The process developed during this work illustrated that the production of (-) ambrafuran 
should be viable on larger scale and that the final product should carry a “natural” label as the 
initial step is done via biocatalysis using the H. roseoniger microorganism, while the second 
step uses the benign zeolites which can be re-used.  Through the re-use of the zeolites as well 
as recycling of the hexane solvent, the process will result in an environmentally friendly 
process as it will have limited impact on the environment in terms of waste disposal.  This is 
in sharp contrast with the current commercial process requiring the waste disposal of very 
harsh chemicals such as pyridine, tosylchloride and butyllitium to name but a few. 
The aim of the project was therefore achieved and scale-up of the complete process to 
approximately 10 L scale should give the data necessary to finalise a technology 
demonstrator which will enable the client to commercialise the process for the production of 
(-) ambrafuran. 
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APPENDIX 
 
 
 
Figure 40: A chromatogram for recrystallized ambradiol analysed by UPLC-MS 
87 
 
 
 
Figure 41: A picture of chromatogram showing (-) ambrafuran peak produced from impure/contaminated ambradiol 
by zeolite CFG-1 
 
 
 
Figure 42: A chromatogram showing (-) ambrafuran peak produced from impure ambradiol by zeolite ZD06014 
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Figure 43: (-) Ambrafuran peak produced in a reaction without MgSO2 anhydrous by zeolite CFG-1 
 
 
 
Figure 44: (-) Ambrafuran peak produced in a reaction with MgSO2 anhydrous by zeolite CFG-1 
 
 
